resourceId,_toolName,organ,tissue,cellLineManifestation,cellLineGeneticDisorder,cellLineCategory,donorId,originYear,strProfile,resistance,contaminatedMisidentified,populationDoublingTime,_resourceName,_pmid,_doi,_publicationTitle,_year,_context,_confidence,_verdict,_usageType
RES63492a0a,NPcis cell line,Nerve,Peripheral nerve sheath,Malignant Peripheral Nerve Sheath Tumor,Neurofibromatosis Type 1,Cancer cell line,,,,,,,NPcis,PMID:32642734,10.1093/noajnl/vdz026,Whole exome sequencing reveals the maintained polyclonal nature from primary to metastatic malignant peripheral nerve sheath tumor in two patients with NF1.,,"Murine MPNST tumor lines established from C57BL6/J Nf1+/−;Trp53+/− (NPcis) expressing GFP-Luciferase were used for the in vitro, and in vivo MPNST tumor growth experiments",0.95,Accept,Experimental Usage
RES46b2e4c2,BJFF.6,Brain,,,,Embryonic stem cell,,,,,,,BJFF.6,PMID:35589737,10.1038/s41467-022-30466-6,Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1.,,NF1 patient heterozygous germline NF1 gene mutations were CRISPR/Cas9-engineered into a single commercially available male control human iPSC line (BJFF.6),0.9,Accept,Experimental Usage
RES2b525570,Normal human Schwann cells (Sciencell),Nerve,Peripheral nerve sheath,,,Finite cell line,,,,,,,Normal human Schwann cells (Sciencell),PMID:35589737,10.1038/s41467-022-30466-6,Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1.,,Normal human Schwann cells (Sciencell) were incubated in SCM (Sciencell) on PDL-coated plates,0.9,Accept,Experimental Usage
RES64383697,TOP-10F' cells,Blood,,,,Finite cell line,,,,,,,TOP-10F',PMID:12057013,10.1186/1471-2164-3-13,Complex splicing pattern generates great diversity in human NF1 transcripts.,,The PCR products were cloned in the pCR2.1-TOPO-vector (Invitrogen) and transformed into TOP-10F' cells.,0.85,Accept,Experimental Usage
RES1945f01f,MCF7,Breast,Mammary epithelium,Breast adenocarcinoma,,Cancer cell line,,,,,,,MCF7,PMID:38216123 | PMID:40507334,10.1016/j.molmet.2024.101876 | 10.3390/cancers17111852,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer. | Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs.,,"Human ER + MCF7 breast cancer cells (HTB-22), were grown in Dulbecco's modified eagle medium | H929, U266B1, U2932, MCF7, and HT229 cell lines were selected based on historic demonstrations of their dependences on corresponding BCL-2-family members",0.9,Accept,Experimental Usage
RESd9a729dd,Nf1 flox/flox calvaria osteoblasts,Bone,Calvaria,,Neurofibromatosis Type 1,Finite cell line,,,,,,,Nf1 flox/flox calvaria osteoblasts,PMID:20200958,10.1002/jbmr.42,Local low-dose lovastatin delivery improves the bone-healing defect caused by Nf1 loss of function in osteoblasts.,,Calvaria osteoblasts were extracted by multiple collagenase/trypsine digestion from 4-day-old Nf1 flox/flox pups,0.8,Accept,Experimental Usage
RESdd4069b7,DH10Bac cells,Bacterial,,,,Finite cell line,,,,,,,DH10Bac,PMID:31836666,10.1074/jbc.RA119.010934,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,,Final baculovirus expression clones were transformed into DH10Bac cells (Thermo Fisher Scientific),0.9,Accept,Experimental Usage
RES723c52d9,BL21(DE3),Bacterial,,,,Finite cell line,,,,,,,BL21(DE3),PMID:31836666,10.1074/jbc.RA119.010934,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,,E. coli expression clones were transformed into BL21(DE3) for expression,0.9,Accept,Experimental Usage
RES649a81c4,Sf9 cells,Insect,,,,Finite cell line,,,,,,,Sf9,PMID:31836666,10.1074/jbc.RA119.010934,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,,baculoviruses were generated by transfection of bacmid DNA into Sf9 cells,0.9,Accept,Experimental Usage
RESfe968e38,Tni-FNL cells,Insect,,,,Finite cell line,,,,,,,Tni-FNL,PMID:31836666,10.1074/jbc.RA119.010934,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,,Titered viruses were used at a multiplicity of infection of 3 to infect Tni-FNL cells,0.9,Accept,Experimental Usage
REScf18c3c5,NF1-null HEK293T cell line,Kidney,Embryonic kidney,,Neurofibromatosis Type 1,Cancer cell line,,,,,,,NF1-null HEK293T,PMID:31836666,10.1074/jbc.RA119.010934,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,,An NF1-null HEK293T cell line was generated using CRISPR to knock out both alleles of NF1,0.95,Accept,Development
RES7f062621,HEK293T cells,Kidney,,,,Cancer cell line,,,,,,,HEK293T,PMID:40590220 | PMID:35789380 | PMID:31836666 | PMID:29402968 | PMID:31015291 | PMID:40225167 | PMID:34415582 | PMID:39269317 | PMID:23175151 | PMID:38216587 | PMID:20554030 | PMID:28166733 | PMID:33934112,10.1172/JCI188932 | 10.1158/2159-8290.CD-21-1671 | 10.1074/jbc.RA119.010934 | 10.1038/s41598-018-20894-0 | 10.1126/scisignal.aau8749 | 10.1155/2023/9628049 | 10.1002/glia.24075 | 10.1158/1078-0432.CCR-24-1750 | 10.1038/bjc.2012.518 | 10.1038/s41467-023-40408-5 | 10.1016/j.jneuroim.2010.05.002 | 10.1186/s12864-017-3519-7 | 10.1038/s41419-021-03716-6,A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice. | PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry. | Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer. | Integrating Functional Analysis in the Next-Generation Sequencing Diagnostic Pipeline of RASopathies. | Proximity biotinylation identifies a set of conformation-specific interactions between Merlin and cell junction proteins. | Functional Assays Combined with Pre-mRNA-Splicing Analysis Improve Variant Classification and Diagnostics for Individuals with Neurofibromatosis Type 1 and Legius Syndrome. | Notch signaling via Hey1 and Id2b regulates Müller glia's regenerative response to retinal injury. | MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath Tumor. | MicroRNA profiling of peripheral nerve sheath tumours identifies miR-29c as a tumour suppressor gene involved in tumour progression. | Epigenetic reprogramming shapes the cellular landscape of schwannoma. | CXCL12 alone is insufficient for gliomagenesis in Nf1 mutant mice. | A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma. | HIF1α-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxia.,,"HEK293T cells (American Type Culture Collection [ATCC], CRL-3216) | All MPNST cell lines (human and mouse) and HEK-293T cells (ATCC; cat. #CRL-3216, RRID:CVCL_0063) were cultured in DMEM:F-12 (1:1) high-glucose media | HEK293T and NF1-null 293T cells were maintained in DMEM with 10% fetal bovine serum | mutant transcripts were expressed in HEK-293T cells. The phosphorylation level of ELK1, which is a downstream substrate of the RAS/MAPK pathway | HEK 293T and immortalized mouse Nf2 Schwann cells, a gift from D. Lallemand...were maintained in Dulbecco's minimum essential medium | HEK 293 T and COS-7 cells were maintained in Dulbecco's Modified Eagle Medium (DMEM) | To study hey1 promoter activity, we transfected HEK 293T cells plated in 24 well tissue culture plates | The SNF96.2 (CRL-2884, RRID: CVCL_K281) human MPNST cell line and the HEK-293T (CRL-3216, RRID: CVCL_0063) cell line were obtained from ATCC | compared with HEK293T cells, which are neurofibromin 1 wildtype (WT) | HEK-293T cells were a gift from Luke Gilbert and cultured in Dulbecco's Modified Eagle Medium | The HEK 293T cell line was purchased from ATCC | U87-MG and HEK293T cells were purchased from ATCC. Cell lines were regularly passaged and were cultured in Dulbecco's Modified Eagle Medium | co-transfected with the packaging plasmids psPAX (Addgene #12260) and pMD2.G (Addgene, #12259) into the human embryonic kidney (HEK) 293T cells",0.95,Accept,Experimental Usage
RESba144dfb,S462TY,Nerve,Peripheral nerve sheath,Malignant Peripheral Nerve Sheath Tumor,Neurofibromatosis Type 1,Cancer cell line,,,,,,,S462TY,PMID:38201517 | PMID:37164978 | PMID:24681606 | PMID:23685747 | PMID:41036607 | PMID:38203448 | PMID:23535903,10.3390/cancers16010089 | 10.1038/s41467-023-38432-6 | 10.18632/oncotarget.1609 | 10.1038/ng.2641 | 10.1158/1535-7163.MCT-24-1053 | 10.3390/ijms25010277 | 10.1158/2159-8290.CD-13-0081,"Synergistic Suppression of NF1 Malignant Peripheral Nerve Sheath Tumor Cell Growth in Culture and Orthotopic Xenografts by Combinational Treatment with Statin and Prodrug Farnesyltransferase Inhibitor PAMAM G4 Dendrimers. | Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities. | Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity. | Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis. | Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors. | FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells. | Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance.",,"The human NF1 MPNST cell line S462TY was the gift of N. Ratner (University of Cincinnati College of Medicine, Cincinnati, OH, USA). It was derived from a xenograft of S462 cells that grew in immune-deficient mice. | MPNST cell lines (STS-26T, S462, S462TY, T265) were obtained from Dr. David Largaespada's laboratory | Immortalized human Schwann cell and MPNST cell lines (S462 [ 34 ], S462-TY [ 35 ], ST8814 [ 36 ], T265 [ 37 ], and STS-26T [ 38 ]) | human MPNST cell lines (ST88-14, STS26T, S462, S462-TY, and T265) | S462-TY cells were cultured in DMEM supplemented with 10% FBS and 1% penicillin/streptomycin at 37°C with 5% CO2 | The S462TY cell line was a kind gift from Dr. Timothy Cripe (Nationwide Children's Hospital Columbus, Columbus, OH, USA) | Immortalized human Schwann cell and MPNST cell lines (S462 ( 45 ), S462-TY ( 35 ), ST8814 ( 46 ), T265 ( 47 ), and STS-26T ( 36 ))",0.95,Accept,Experimental Usage
RES0f0c862a,iSC,Nerve,Schwann cells,,,Finite cell line,,,,,,,iSC,PMID:38201517 | PMID:18367665,10.3390/cancers16010089 | 10.1124/jpet.107.135830,Synergistic Suppression of NF1 Malignant Peripheral Nerve Sheath Tumor Cell Growth in Culture and Orthotopic Xenografts by Combinational Treatment with Statin and Prodrug Farnesyltransferase Inhibitor PAMAM G4 Dendrimers. | Induction of apoptosis in neurofibromatosis type 1 malignant peripheral nerve sheath tumor cell lines by a combination of novel farnesyl transferase inhibitors and lovastatin.,,"The immortalized normal rat Schwann cell line iSC was provided by E. M. Shooter (Stanford University, Stanford, CA, USA). | Normal, spontaneously immortal rat Schwann cell clones (iSC) isolated from sciatic nerves were a generous gift from E.M. Shooter",0.9,Accept,Experimental Usage
RESd602b122,A549,Lung,,Non-small cell lung carcinoma,,Cancer cell line,,,,,,,A549,PMID:38201517,10.3390/cancers16010089,Synergistic Suppression of NF1 Malignant Peripheral Nerve Sheath Tumor Cell Growth in Culture and Orthotopic Xenografts by Combinational Treatment with Statin and Prodrug Farnesyltransferase Inhibitor PAMAM G4 Dendrimers.,,"The human non-small cell carcinoma cell line A549 was obtained from Cell Lines Resource, Karmanos Cancer Institute, Detroit, MI.",0.85,Accept,Experimental Usage
RES8c79577c,ST88-14,Nerve,Peripheral nerve sheath,Malignant Peripheral Nerve Sheath Tumor,Neurofibromatosis Type 1,Cancer cell line,,,,,,,ST88-14,PMID:38201517 | PMID:41022755 | PMID:39269317 | PMID:18367665 | PMID:37246765 | PMID:33658640 | PMID:24824755 | PMID:39129390 | PMID:18413802 | PMID:24681606 | PMID:23685747 | PMID:20049725 | PMID:32642733 | PMID:18483311 | PMID:38127282 | PMID:38216572 | PMID:38203448 | PMID:23535903 | PMID:41036607 | PMID:33032988,10.3390/cancers16010089 | 10.1038/s41467-025-63619-4 | 10.1158/1078-0432.CCR-24-1750 | 10.1124/jpet.107.135830 | 10.1093/neuonc/noad097 | 10.1038/s41416-021-01270-8 | 10.1371/journal.pone.0096733 | 10.1002/1878-0261.13704 | 10.1158/1535-7163.MCT-07-0518 | 10.18632/oncotarget.1609 | 10.1038/ng.2641 | 10.1002/emmm.200900027 | 10.1093/noajnl/vdz061 | 10.1158/1535-7163.MCT-07-2335 | 10.1158/1078-0432.CCR-23-2548 | 10.1038/s41467-024-44755-9 | 10.3390/ijms25010277 | 10.1158/2159-8290.CD-13-0081 | 10.1158/1535-7163.MCT-24-1053 | 10.1158/0008-5472.CAN-20-1365,"Synergistic Suppression of NF1 Malignant Peripheral Nerve Sheath Tumor Cell Growth in Culture and Orthotopic Xenografts by Combinational Treatment with Statin and Prodrug Farnesyltransferase Inhibitor PAMAM G4 Dendrimers. | Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors. | MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath Tumor. | Induction of apoptosis in neurofibromatosis type 1 malignant peripheral nerve sheath tumor cell lines by a combination of novel farnesyl transferase inhibitors and lovastatin. | Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology. | Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours. | BNIP3 regulates AT101 [(-)-gossypol] induced death in malignant peripheral nerve sheath tumor cells. | Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors. | Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells. | Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity. | Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis. | Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene. | KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors. | Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors. | Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression. | Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance. | FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells. | Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance. | Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors. | Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.",,"The MPNST cell line ST88-14 was obtained from T. Glover (University of Michigan, Ann Arbor, MI, USA). | Human MPNST cell line ST88-14, S462 and a patient-derived xenoline RHT92 were kindly provided by Melissa L. Fishel | The ST88-14 (RRID: CVCL_8916) and M724 (MPNST724, RRID: CVCL_AU20) human MPNST cell lines were gifted by Dr. Jonathan A. Fletcher | NF90-8 and ST88-14 MPNST cell lines were generously donated by T. Glover (University of Michigan, Ann Arbor, MI) | PDX cells and the MPNST cell line, ST88-14 (gift from Dr. Nancy Ratner, PhD, University of Cincinnati) | malignant peripheral nerve sheath tumour (MPNST) cell lines ST88-14, S462 and NF90-8 | T265-2c cells, ST88-14 cells and 90-8 cells, the human NF1-associated MPNST lines used in this study | Two million ST88‐14 (RRID: CVCL_8916) cells mixed 1 : 1 with Matrigel | ST8814 was derived from a patient with NF1-associated MPNST of the thigh | Immortalized human Schwann cell and MPNST cell lines (S462 [ 34 ], S462-TY [ 35 ], ST8814 [ 36 ], T265 [ 37 ], and STS-26T [ 38 ]) | human MPNST cell lines (ST88-14, STS26T, S462, S462-TY, and T265) | We maintained MPNST cell lines ST88-14, STS26T, S520, S462, 88-3, 90-8 and YST1 | Several cell lines derived from MPNSTs were used: S462 and ST88-14 (provided by Dr Nancy Ratner) | MPNST cell lines STS26T, ST8814, ST88-3 S462, T265p21, S520, 90–8, and YST1...All cell lines were from NF1 patients except YST-1 and STS26T | ST-8814 and S462 cells were obtained from Dr. Andrew Tee (Cardiff University) | Patient-derived neurofibroma (NF95.11b, NF95.6) or MPNST (SNF02.2, SNF94.3, SNF96.2, ST88-14) cell lines | The MPNST cell lines STS26T, T265, and ST8814 have been reported before and were gifted by Dr. Nancy Ratner | Immortalized human Schwann cell and MPNST cell lines (S462 ( 45 ), S462-TY ( 35 ), ST8814 ( 46 ), T265 ( 47 ), and STS-26T ( 36 )) | ST88-14 is an established NF1-deficient MPNST cell line | STS26T, ST8814 and NF90.8 were kindly provided by Dr. Gregory Riggins at Johns Hopkins University",0.95,Accept,Experimental Usage
RES13ccb15b,MCF10A,Breast,Breast epithelium,,,Finite cell line,,,,,,,MCF10A,PMID:38201517,10.3390/cancers16010089,Synergistic Suppression of NF1 Malignant Peripheral Nerve Sheath Tumor Cell Growth in Culture and Orthotopic Xenografts by Combinational Treatment with Statin and Prodrug Farnesyltransferase Inhibitor PAMAM G4 Dendrimers.,,"The human normal breast epithelial MCF10A cell line was obtained from Cell Lines Resource, Karmanos Cancer Institute, Detroit, MI",0.85,Accept,Experimental Usage
RESd6bdbe98,murine NF2 −/− Schwann cell line,Nerve,Peripheral nerve sheath,,Neurofibromatosis Type 2,Cancer cell line,,,,,,,murine NF2 −/− Schwann,PMID:30617350,10.1038/s41596-018-0105-7,"A cerebellopontine angle mouse model for the investigation of tumor biology, hearing, and neurological function in NF2-related vestibular schwannoma.",,"We used a murine NF2 −/− Schwann cell line (we obtained this as a gift from X. Breakefield, Massachusetts General Hospital) in our study.",0.9,Accept,Experimental Usage
RES83633cde,HEI-193,Nerve,Peripheral nerve sheath,Schwannoma,Neurofibromatosis Type 2,Cancer cell line,,,,,,,HEI-193,PMID:21111000 | PMID:38216587 | PMID:30617350 | PMID:30274821,10.1016/j.jneumeth.2010.10.021 | 10.1038/s41467-023-40408-5 | 10.1038/s41596-018-0105-7 | 10.1016/j.ebiom.2018.09.042,"A novel imaging-compatible sciatic nerve schwannoma model. | Epigenetic reprogramming shapes the cellular landscape of schwannoma. | A cerebellopontine angle mouse model for the investigation of tumor biology, hearing, and neurological function in NF2-related vestibular schwannoma. | Synergistic effect of Nutlin-3 combined with MG-132 on schwannoma cells through restoration of merlin and p53 tumour suppressors.",,"Human schwannoma cell line HEI-193 was established from a benign schwannoma tumor from an NF2 patient immortalized with retroviral mediated HPV E6-E7 gene expression | HEI-193 schwannoma cells were a gift from Marco Giovannini and cultured in Dulbecco's Modified Eagle Medium | We have successfully grown murine NF2 −/− Schwann cells in syngeneic mice and human HEI-193 schwannoma cells in nude mice to establish schwannomas in the CPA model. | The HEI-193, an HPV E6-E7 immortalized schwannoma cell line, was a kind gift from Dr. Weg M. Ongkeko",0.95,Accept,Experimental Usage
RES27a80654,ipNF05.5 (mixed clone),Nerve,Peripheral nerve sheath,Plexiform Neurofibroma,Neurofibromatosis Type 1,,,,,,,,ipNF05.5 (mixed clone),PMID:35741605,10.3390/brainsci12060720,Integrated Drug Mining Reveals Actionable Strategies Inhibiting Plexiform Neurofibromas.,,"five cell lines had available transcriptome data, which were downloaded via syn22351884, including ipNF05.5 (mixed clone), ipNF05.5 (single clone)",0.95,Accept,Experimental Usage
RESc8a1bf77,ipNF05.5 (single clone),Nerve,Peripheral nerve sheath,Plexiform Neurofibroma,Neurofibromatosis Type 1,,,,,,,,ipNF05.5 (single clone),PMID:35741605 | PMID:40723243,10.3390/brainsci12060720 | 10.3390/cancers17142359,Integrated Drug Mining Reveals Actionable Strategies Inhibiting Plexiform Neurofibromas. | The Combination of HSP90 Inhibitors and Selumetinib Reinforces the Inhibitory Effects on Plexiform Neurofibromas.,,"five cell lines had available transcriptome data, which were downloaded via syn22351884, including ipNF05.5 (mixed clone), ipNF05.5 (single clone) | pNF cell lines, ipNF95.11bC, ipnNF95.11c, ipNF05.5 Single Clone, and ipNF05.5 Mixed Clones were obtained from the American Type Culture Collection",0.95,Accept,Experimental Usage
RES8555ee4e,ipNF95.11bC,Nerve,Peripheral nerve sheath,Plexiform Neurofibroma,Neurofibromatosis Type 1,,,,,,,,ipNF95.11bC,PMID:35741605 | PMID:39129390 | PMID:40862755 | PMID:36689660 | PMID:39061138 | PMID:40723243,10.3390/brainsci12060720 | 10.1002/1878-0261.13704 | 10.3390/cells14161276 | 10.1073/pnas.2208960120 | 10.3390/cancers16142498 | 10.3390/cancers17142359,Integrated Drug Mining Reveals Actionable Strategies Inhibiting Plexiform Neurofibromas. | Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors. | Fibroblasts Attenuate Anti-Tumor Drug Efficacy in Tumor Cells via Paracrine Interactions with Tumor Cells in 3D Plexiform Neurofibroma Cultures. | Destabilizing NF1 variants act in a dominant negative manner through neurofibromin dimerization. | A Fibroblast-Derived Secretome Stimulates the Growth and Invasiveness of 3D Plexiform Neurofibroma Spheroids. | The Combination of HSP90 Inhibitors and Selumetinib Reinforces the Inhibitory Effects on Plexiform Neurofibromas.,,"including ipNF05.5 (mixed clone), ipNF05.5 (single clone), ipNF95.11bC, ipNF95.6, and ipnNF95.11c | ipNF95.11b 'C' (hTERT NF1 ipNF95.11b C, RRID: CVCL_UI67; +/− NF1 ) cells | The following immortalized human plexiform neurofibroma cell lines (Nf1−/−; hereafter called pNF1 cells) described in [23] were used: ipNF95.11b C and ipNF05.5 purchased from ATCC. | ipNF95.11b C was purchased from ATCC, and CRISPR technology was used to generate a homozygous NF1 knockout clone | The following immortalized human plexiform neurofibroma cell lines (hereafter called pNF1 cells) described in [ 36 ] were used: ipNF95.11b C | pNF cell lines, ipNF95.11bC, ipnNF95.11c, ipNF05.5 Single Clone, and ipNF05.5 Mixed Clones were obtained from the American Type Culture Collection",0.95,Accept,Experimental Usage
RES53c1db9a,ipNF95.6,Nerve,Peripheral nerve sheath,Plexiform Neurofibroma,Neurofibromatosis Type 1,,,,,,,,ipNF95.6,PMID:35741605 | PMID:33934112 | PMID:33442015 | PMID:38136356,10.3390/brainsci12060720 | 10.1038/s41419-021-03716-6 | 10.1038/s41591-020-01193-6 | 10.3390/cancers15245811,Integrated Drug Mining Reveals Actionable Strategies Inhibiting Plexiform Neurofibromas. | HIF1α-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxia. | Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial. | Drug Responses in Plexiform Neurofibroma Type I (PNF1) Cell Lines Using High-Throughput Data and Combined Effectiveness and Potency.,,"including ipNF05.5 (mixed clone), ipNF05.5 (single clone), ipNF95.11bC, ipNF95.6, and ipnNF95.11c | human ipNF95.6 plexiform neurofibroma cells (kindly provided by Dr. Margaret R. Wallace) | Human immortalized NF1−/− Schwann cells (iPNF95.6) were plated in triplicate at a density of 5,000 cells/well | ...NF1 −/− plexiform neurofibroma cell lines (PNF1 cells) ipNF05.5-MX, ipNF06.2A, ipNF95.11b C/T, and ipNF95.6 as test lines...",0.95,Accept,Experimental Usage
RESd7276863,ipnNF95.11c,Nerve,Peripheral nerve sheath,Plexiform Neurofibroma,Neurofibromatosis Type 1,,,,,,,,ipnNF95.11c,PMID:35741605 | PMID:39129390 | PMID:38136356 | PMID:40723243,10.3390/brainsci12060720 | 10.1002/1878-0261.13704 | 10.3390/cancers15245811 | 10.3390/cancers17142359,Integrated Drug Mining Reveals Actionable Strategies Inhibiting Plexiform Neurofibromas. | Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors. | Drug Responses in Plexiform Neurofibroma Type I (PNF1) Cell Lines Using High-Throughput Data and Combined Effectiveness and Potency. | The Combination of HSP90 Inhibitors and Selumetinib Reinforces the Inhibitory Effects on Plexiform Neurofibromas.,,"including ipNF05.5 (mixed clone), ipNF05.5 (single clone), ipNF95.11bC, ipNF95.6, and ipnNF95.11c | ipnNF95.11C (hTERT NF1 ipnNF95.11c, RRID: CVCL_UI69; NF −/− ) and ipNF95.11b 'C' | ...immortalized NF1 −/−, NF1 +/−, and NF1 +/+ cell lines [16], with the fluorescence intensity indicating survival and proliferation after treatment... | pNF cell lines, ipNF95.11bC, ipnNF95.11c, ipNF05.5 Single Clone, and ipNF05.5 Mixed Clones were obtained from the American Type Culture Collection",0.95,Accept,Experimental Usage
RESabb7add4,COS-7,Kidney,,,,Cancer cell line,,,,,,,COS-7,PMID:40225167,10.1155/2023/9628049,Functional Assays Combined with Pre-mRNA-Splicing Analysis Improve Variant Classification and Diagnostics for Individuals with Neurofibromatosis Type 1 and Legius Syndrome.,,HEK 293 T and COS-7 cells were maintained in Dulbecco's Modified Eagle Medium (DMEM),0.9,Accept,Experimental Usage
RESabd0cc70,Nf1-/- mouse embryo fibroblasts,Embryonic tissue,,,Neurofibromatosis Type 1,Finite cell line,,,,,,,Nf1-/- mouse embryo fibroblasts,PMID:21199799,10.1158/0008-5472.CAN-10-2732,Dose-dependent effects of focal fractionated irradiation on secondary malignant neoplasms in Nf1 mutant mice.,,"Nf1−/−, Nf1+/−, and wildtype mouse embryo fibroblasts were generated as previously described (15).",0.9,Accept,Experimental Usage
RES7d7c375d,T265-2c,Nerve,Peripheral nerve sheath,Malignant Peripheral Nerve Sheath Tumor,Neurofibromatosis Type 1,Cancer cell line,,,,,,,T265-2c,PMID:24824755,10.1371/journal.pone.0096733,BNIP3 regulates AT101 [(-)-gossypol] induced death in malignant peripheral nerve sheath tumor cells.,,"T265-2c cells, ST88-14 cells and 90-8 cells, the human NF1-associated MPNST lines used in this study",0.9,Accept,Experimental Usage
RES4d55b268,90-8,Nerve,Peripheral nerve sheath,Malignant Peripheral Nerve Sheath Tumor,Neurofibromatosis Type 1,Cancer cell line,,,,,,,90-8,PMID:24824755 | PMID:20049725 | PMID:32642733 | PMID:18483311,10.1371/journal.pone.0096733 | 10.1002/emmm.200900027 | 10.1093/noajnl/vdz061 | 10.1158/1535-7163.MCT-07-2335,BNIP3 regulates AT101 [(-)-gossypol] induced death in malignant peripheral nerve sheath tumor cells. | Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene. | KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors. | Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors.,,"T265-2c cells, ST88-14 cells and 90-8 cells, the human NF1-associated MPNST lines used in this study | We maintained MPNST cell lines ST88-14, STS26T, S520, S462, 88-3, 90-8 and YST1 | 90-8 and the sporadic MPNST-derived STS-26T (provided by Dr Eric Legius) | MPNST cell lines STS26T, ST8814, ST88-3 S462, T265p21, S520, 90–8, and YST1...All cell lines were from NF1 patients except YST-1 and STS26T",0.9,Accept,Experimental Usage
RES68239221,NF96.2,Nerve,Peripheral nerve sheath,Malignant Peripheral Nerve Sheath Tumor,Neurofibromatosis Type 1,Cancer cell line,,,,,,,NF96.2,PMID:24040940 | PMID:33032988,10.1186/1479-5876-11-213 | 10.1158/0008-5472.CAN-20-1365,Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors. | Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,"MPNST-derived cell lines NF96.2, NF02.2, and NF94.3 (ATCC) and benign neurofibroma cell lines were maintained in 5% CO2 at 37C | NF94.3, NF96.2, NF10.1 and NF11.1 were kindly provided by Dr. Margaret Wallace at University of Florida",0.9,Accept,Experimental Usage
RESc0c71d85,NF02.2,Nerve,Peripheral nerve sheath,Malignant Peripheral Nerve Sheath Tumor,Neurofibromatosis Type 1,Cancer cell line,,,,,,,NF02.2,PMID:24040940,10.1186/1479-5876-11-213,Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors.,,"MPNST-derived cell lines NF96.2, NF02.2, and NF94.3 (ATCC) and benign neurofibroma cell lines were maintained in 5% CO2 at 37C",0.9,Accept,Experimental Usage
RESae0432c8,NF94.3,Nerve,Peripheral nerve sheath,Malignant Peripheral Nerve Sheath Tumor,Neurofibromatosis Type 1,Cancer cell line,,,,,,,NF94.3,PMID:24040940 | PMID:33032988,10.1186/1479-5876-11-213 | 10.1158/0008-5472.CAN-20-1365,Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors. | Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,"MPNST-derived cell lines NF96.2, NF02.2, and NF94.3 (ATCC) and benign neurofibroma cell lines were maintained in 5% CO2 at 37C | NF94.3, NF96.2, NF10.1 and NF11.1 were kindly provided by Dr. Margaret Wallace at University of Florida",0.9,Accept,Experimental Usage
RESbaa9fdad,HEK293 cells,Kidney,Embryonic kidney,,,Cancer cell line,,,,,,,HEK293,PMID:33673681 | PMID:30531922,10.3390/cancers13050999 | 10.1038/s41591-018-0263-8,Hybrid Minigene Assay: An Efficient Tool to Characterize mRNA Splicing Profiles of | The molecular landscape of glioma in patients with Neurofibromatosis 1.,,HEK293 cells (6 × 10 5 ) were transfected with 1 µg of the wild type or the mutated minigene | standard curves for quantitative analysis were prepared with serially diluted QuickPreps of ALT[+] U2OS and ALT[-] HEK293 cell lines,0.95,Accept,Experimental Usage
RES98351e60,LLC-PK1 ATCC CL-101,Kidney,Kidney epithelial,,,Finite cell line,,,,,,,LLC-PK1 ATCC CL-101,PMID:34630515,10.3389/fgene.2021.721045,Assessment of Mosaicism and Detection of Cryptic Alleles in CRISPR/Cas9-Engineered Neurofibromatosis Type 1 and ,,"In vitro design validation was performed using a porcine kidney epithelial cell line (LLC-PK1 ATCC CL-101 ™ ; American Type Culture Collection (ATCC), Manassas, VA)",0.85,Accept,Experimental Usage
RES3224a315,MiaPaCa-2,Pancreas,Pancreas,Pancreatic carcinoma,,Cancer cell line,,,,,,,MiaPaCa-2,PMID:33934112 | PMID:32457840,10.1038/s41419-021-03716-6 | 10.3389/fonc.2020.00687,"HIF1α-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxia. | TGFβ Signaling Increases Net Acid Extrusion, Proliferation and Invasion in Panc-1 Pancreatic Cancer Cells: SMAD4 Dependence and Link to Merlin/NF2 Signaling.",,"human pancreatic carcinoma cells (MiaPaCa-2 and PANC1) | Human PDAC cell lines MIAPaCa-2, Panc-1, BxPC-3, and AsPC-1 were acquired from American Type Culture Collection (ATCC, Rockville, MD, USA)",0.9,Accept,Experimental Usage
RES928f1713,PANC1,Pancreas,Pancreas,Pancreatic carcinoma,,Cancer cell line,,,,,,,PANC1,PMID:33934112 | PMID:32457840,10.1038/s41419-021-03716-6 | 10.3389/fonc.2020.00687,"HIF1α-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxia. | TGFβ Signaling Increases Net Acid Extrusion, Proliferation and Invasion in Panc-1 Pancreatic Cancer Cells: SMAD4 Dependence and Link to Merlin/NF2 Signaling.",,"human pancreatic carcinoma cells (MiaPaCa-2 and PANC1) | Human PDAC cell lines MIAPaCa-2, Panc-1, BxPC-3, and AsPC-1 were acquired from American Type Culture Collection (ATCC, Rockville, MD, USA)",0.9,Accept,Experimental Usage
RESd23e6c85,BxPc3,Pancreas,Pancreas,Pancreatic adenocarcinoma,,Cancer cell line,,,,,,,BxPc3,PMID:33934112 | PMID:32457840,10.1038/s41419-021-03716-6 | 10.3389/fonc.2020.00687,"HIF1α-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxia. | TGFβ Signaling Increases Net Acid Extrusion, Proliferation and Invasion in Panc-1 Pancreatic Cancer Cells: SMAD4 Dependence and Link to Merlin/NF2 Signaling.",,"human pancreatic adenocarcinoma cells (BxPc3) | Human PDAC cell lines MIAPaCa-2, Panc-1, BxPC-3, and AsPC-1 were acquired from American Type Culture Collection (ATCC, Rockville, MD, USA)",0.9,Accept,Experimental Usage
RES660e82ea,AsPC-1,Pancreas,Pancreatic ductal epithelium,,,Cancer cell line,,,,,,,AsPC-1,PMID:32457840,10.3389/fonc.2020.00687,"TGFβ Signaling Increases Net Acid Extrusion, Proliferation and Invasion in Panc-1 Pancreatic Cancer Cells: SMAD4 Dependence and Link to Merlin/NF2 Signaling.",,"Human PDAC cell lines MIAPaCa-2, Panc-1, BxPC-3, and AsPC-1 were acquired from American Type Culture Collection (ATCC, Rockville, MD, USA)",0.85,Accept,Experimental Usage
RES00c86d4a,HPDE H6c7,Pancreas,Pancreatic ductal epithelium,,,Finite cell line,,,,,,,HPDE H6c7,PMID:32457840,10.3389/fonc.2020.00687,"TGFβ Signaling Increases Net Acid Extrusion, Proliferation and Invasion in Panc-1 Pancreatic Cancer Cells: SMAD4 Dependence and Link to Merlin/NF2 Signaling.",,Immortalized human pancreatic ductal epithelial (HPDE H6c7) cells were a kind gift from Dr. Ming-Sound Tsao at Ontario Cancer Institute,0.85,Accept,Experimental Usage
RES8ba7d57b,Ben-Men-1,Brain,Meninges,Meningioma,Neurofibromatosis Type 2,Cancer cell line,,,,,,,Ben-Men-1,PMID:33273014 | PMID:28126595 | PMID:26219339 | PMID:36148553,10.1074/jbc.RA120.014960 | 10.1016/j.ebiom.2017.01.020 | 10.18632/oncotarget.4858 | 10.1093/brain/awac342,mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition. | Global Proteome and Phospho-proteome Analysis of Merlin-deficient Meningioma and Schwannoma Identifies PDLIM2 as a Novel Therapeutic Target. | A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas. | Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma.,,"Human cell lines included an NF2-null immortalized MN line Ben-Men-1 | Ben-Men-1 cells and primary meningioma cells were routinely grown in DMEM, 10% FBS and 100 U/ml Penicillin/Streptomycin | Cell lines included immortalized NF2-deficient meningioma Ben-Men-1 | meningioma cell lines BenMen-1 (Grade 1) and KT21-MG1 (Grade 3) were cultured in DMEM/10% FBS",0.9,Accept,Experimental Usage
RESc40180a9,AC-CRISPR,Brain,Arachnoid,,Neurofibromatosis Type 2,Finite cell line,,,,,,,AC-CRISPR,PMID:33273014,10.1074/jbc.RA120.014960,mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition.,,"NF2 AC-CRISPR, and two independent human primary MN",0.85,Accept,Experimental Usage
RESd4d873f7,MN1-LF,Brain,Meninges,Meningioma,Neurofibromatosis Type 2,Cancer cell line,,,,,,,MN1-LF,PMID:33273014,10.1074/jbc.RA120.014960,mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition.,,"we generated an immortalized human MN line, MN1-LF from an independent NF2-null human primary MN cell line",0.85,Accept,Experimental Usage
RES6448cbce,H358 cells,Lung,,,,Cancer cell line,,,,,,,H358,PMID:38502231,10.1172/JCI176748,STING activation reprograms the microenvironment to sensitize NF1-related malignant peripheral nerve sheath tumors for immunotherapy.,,H358 cells (shared by the Kate O'Donnell laboratory at UT Southwestern) were KRAS mutant human lung cancer cells,0.8,Accept,Experimental Usage
RES7787dd40,S462,Nerve,Peripheral nerve sheath,Malignant Peripheral Nerve Sheath Tumor,Neurofibromatosis Type 1,Cancer cell line,,,,,,,S462,PMID:41022755 | PMID:32383545 | PMID:33658640 | PMID:38502231 | PMID:23328114 | PMID:37164978 | PMID:24681606 | PMID:23685747 | PMID:30055648 | PMID:20049725 | PMID:32642733 | PMID:18483311 | PMID:38127282 | PMID:41001593 | PMID:32948135 | PMID:37410426 | PMID:23535903 | PMID:35511749,10.1038/s41467-025-63619-4 | 10.15252/embr.201949117 | 10.1038/s41416-021-01270-8 | 10.1172/JCI176748 | 10.18632/oncotarget.793 | 10.1038/s41467-023-38432-6 | 10.18632/oncotarget.1609 | 10.1038/ng.2641 | 10.1186/s13104-018-3630-0 | 10.1002/emmm.200900027 | 10.1093/noajnl/vdz061 | 10.1158/1535-7163.MCT-07-2335 | 10.1158/1078-0432.CCR-23-2548 | 10.1080/23723556.2025.2561292 | 10.1186/s12885-020-07397-w | 10.1158/1078-0432.CCR-23-0749 | 10.1158/2159-8290.CD-13-0081 | 10.1158/1535-7163.MCT-21-0947,"Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors. | Hexokinase 2 displacement from mitochondria-associated membranes prompts Ca | Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours. | STING activation reprograms the microenvironment to sensitize NF1-related malignant peripheral nerve sheath tumors for immunotherapy. | Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition. | Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities. | Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity. | Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis. | Testing ATRA and MEK inhibitor PD0325901 effectiveness in a nude mouse model for human MPNST xenografts. | Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene. | KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors. | Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors. | Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression. | Loss of Schwann cell's normal rhythmic core clock gene expression and gain of rhythmic expression of oncogenic driver genes in malignant NF1-associated peripheral nerve sheath tumor. | Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model. | CDK4/6-MEK Inhibition in MPNSTs Causes Plasma Cell Infiltration, Sensitization to PD-L1 Blockade, and Tumor Regression. | Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance. | A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.",,"Human MPNST cell line ST88-14, S462 and a patient-derived xenoline RHT92 were kindly provided by Melissa L. Fishel | human malignant peripheral nerve sheath tumor S462 cells, human plexiform neurofibroma PN 04.4 cells | malignant peripheral nerve sheath tumour (MPNST) cell lines ST88-14, S462 and NF90-8 | S462 cells were human NF1–related MPNST cells (SCC414, MilliporeSigma). | cells were seeded at 1.0 × 104 (S462 cell-line) or 3.0 × 104 (2884 and 2885 cell-lines) cells/well | MPNST cell lines (STS-26T, S462, S462TY, T265) were obtained from Dr. David Largaespada's laboratory | Immortalized human Schwann cell and MPNST cell lines (S462 [ 34 ], S462-TY [ 35 ], ST8814 [ 36 ], T265 [ 37 ], and STS-26T [ 38 ]) | human MPNST cell lines (ST88-14, STS26T, S462, S462-TY, and T265) | Human MPNST cell lines S462 and T265 were described previously...NF1 associated MPNST derived from S462 but not T265 cells form solid subcutaneous tumors | We maintained MPNST cell lines ST88-14, STS26T, S520, S462, 88-3, 90-8 and YST1 | Several cell lines derived from MPNSTs were used: S462 and ST88-14 (provided by Dr Nancy Ratner) | MPNST cell lines STS26T, ST8814, ST88-3 S462, T265p21, S520, 90–8, and YST1...All cell lines were from NF1 patients except YST-1 and STS26T | ST-8814 and S462 cells were obtained from Dr. Andrew Tee (Cardiff University) | Human T265, S462, and NSF1 cell lines of malignant peripheral nerve sheath tumors (MPNSTs) being associated with neurofibromatosis type 1 | Human MPNST cell lines (S462, T265, and NSF1) were analyzed and have been described in detail in our previous studies | NF1-associated S462, Cellosaurus RRID: CVCL_1Y70) were maintained at 37°C | Immortalized human Schwann cell and MPNST cell lines (S462 ( 45 ), S462-TY ( 35 ), ST8814 ( 46 ), T265 ( 47 ), and STS-26T ( 36 )) | STS-26T (19), HS-PSS, HS-sch2 (20), S462 (21), and sNF96.2 (22) cell lines were previously established in other laboratories.",0.95,Accept,Experimental Usage
RESbf9e0bf2,cis MPNST cell line,Nerve,Peripheral nerve sheath,Malignant Peripheral Nerve Sheath Tumor,Neurofibromatosis Type 1,Cancer cell line,,,,,,,cis MPNST,PMID:38502231 | PMID:35393510,10.1172/JCI176748 | 10.1038/s41418-022-00991-4,STING activation reprograms the microenvironment to sensitize NF1-related malignant peripheral nerve sheath tumors for immunotherapy. | Tumor growth of neurofibromin-deficient cells is driven by decreased respiration and hampered by NAD,,The cis MPNST cell line was generated in the laboratory by harvesting tumors from cis MPNST mice. | cisMPNST cells were derived from spontaneous MPNSTs arising in cis Nf1+/−;P53+/− mice,0.9,Accept,Experimental Usage
RES9709e143,HTS-Luc MPNST cell line,Nerve,Peripheral nerve sheath,Malignant Peripheral Nerve Sheath Tumor,Neurofibromatosis Type 1,Cancer cell line,,,,,,,HTS-Luc MPNST,PMID:38502231,10.1172/JCI176748,STING activation reprograms the microenvironment to sensitize NF1-related malignant peripheral nerve sheath tumors for immunotherapy.,,The HTS-Luc MPNST cell line was described before (48).,0.9,Accept,Experimental Usage
RESd2d7bbb3,pNF9511bc,Nerve,Peripheral nerve sheath,Plexiform Neurofibroma,Neurofibromatosis Type 1,Finite cell line,,,,,,,pNF9511bc,PMID:41022755,10.1038/s41467-025-63619-4,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors.,,"Immortalized human pNF cell lines pNF9511bc and ipNF03.3, immortalized human normal Schwann cell line ipn023λ, were generated by the Wallace's lab",0.9,Accept,Experimental Usage
RES4029030f,ipNF03.3,Nerve,Peripheral nerve sheath,Plexiform Neurofibroma,Neurofibromatosis Type 1,Finite cell line,,,,,,,ipNF03.3,PMID:41022755,10.1038/s41467-025-63619-4,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors.,,"Immortalized human pNF cell lines pNF9511bc and ipNF03.3, immortalized human normal Schwann cell line ipn023λ, were generated by the Wallace's lab",0.9,Accept,Experimental Usage
RES22f213dc,ipn023λ,Nerve,Peripheral nerve sheath,,,Finite cell line,,,,,,,ipn023λ,PMID:41022755,10.1038/s41467-025-63619-4,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors.,,"immortalized human normal Schwann cell line ipn023λ, were generated by the Wallace's lab",0.9,Accept,Experimental Usage
RESbf7021d2,RHT92,Nerve,Peripheral nerve sheath,Malignant Peripheral Nerve Sheath Tumor,Neurofibromatosis Type 1,Cancer cell line,,,,,,,RHT92,PMID:41022755,10.1038/s41467-025-63619-4,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors.,,"Human MPNST cell line ST88-14, S462 and a patient-derived xenoline RHT92 were kindly provided by Melissa L. Fishel",0.9,Accept,Experimental Usage
RESec88ccdf,LN229,Brain,Brain,Glioma,Neurofibromatosis Type 1,Cancer cell line,,,,,,,LN229,PMID:41022755 | PMID:38714355,10.1038/s41467-025-63619-4 | 10.1158/1535-7163.MCT-23-0510,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors. | MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma.,,"The NF1-deficient LN229 glioma cell line was kindly provided by Karisa Schreck of the Johns Hopkins University | LN229 was obtained from ATCC, T98G was a gift from the Laterra laboratory, and both were cultured as recommended",0.9,Accept,Experimental Usage
RES0162cd28,2V6.11,Unknown,,,,Finite cell line,,,,,,,2V6.11,PMID:41022755,10.1038/s41467-025-63619-4,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors.,,2V6.11 cells were purchased from Cytion Cell Lines Services LLC,0.85,Accept,Experimental Usage
RESd0d2a3a9,FiPS,Unknown,,,,Embryonic stem cell,,,,,,,FiPS,PMID:41022755,10.1038/s41467-025-63619-4,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors.,,"FiPS, a WT human iPSC line derived from fibroblast, and its isogenic NF1 iPSC generated by CRISPR",0.9,Accept,Experimental Usage
RESdc14408d,"NF1−/−−/− edited FiPS Ctrl1-SV4F-7, D12",Unknown,,,Neurofibromatosis Type 1,Embryonic stem cell,,,,,,,"NF1−/−−/− edited FiPS Ctrl1-SV4F-7, D12",PMID:41022755,10.1038/s41467-025-63619-4,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors.,,"its isogenic NF1 iPSC generated by CRISPR (NF1−/−−/− edited FiPS Ctrl1-SV4F-7, D12, Sex: XY)",0.9,Accept,Experimental Usage
RES63dfec23,3PNF_SiPSsv_MM_11,Nerve,,Plexiform Neurofibroma,Neurofibromatosis Type 1,Embryonic stem cell,,,,,,,3PNF_SiPSsv_MM_11,PMID:41022755,10.1038/s41467-025-63619-4,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors.,,"as well as the pNF-derived NF1−/− iPSC 3MM (3PNF_SiPSsv_MM_11, Sex: XX)",0.9,Accept,Experimental Usage
RES0b303b9d,M724,Nerve,Peripheral nerve sheath,Malignant Peripheral Nerve Sheath Tumor,Neurofibromatosis Type 1,Cancer cell line,,,,,,,M724,PMID:39269317,10.1158/1078-0432.CCR-24-1750,MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath Tumor.,,"The ST88-14 (RRID: CVCL_8916) and M724 (MPNST724, RRID: CVCL_AU20) human MPNST cell lines were gifted by Dr. Jonathan A. Fletcher",0.95,Accept,Experimental Usage
RES65ffa5bf,SNF96.2,Nerve,Peripheral nerve sheath,Malignant Peripheral Nerve Sheath Tumor,Neurofibromatosis Type 1,Cancer cell line,,,,,,,SNF96.2,PMID:39269317 | PMID:23175151 | PMID:29438698 | PMID:40025578 | PMID:36322658 | PMID:35511749 | PMID:32642733 | PMID:38216572,10.1158/1078-0432.CCR-24-1750 | 10.1038/bjc.2012.518 | 10.1016/j.ccell.2018.01.005 | 10.1186/s40478-025-01965-6 | 10.1126/sciadv.abo5442 | 10.1158/1535-7163.MCT-21-0947 | 10.1093/noajnl/vdz061 | 10.1038/s41467-024-44755-9,MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath Tumor. | MicroRNA profiling of peripheral nerve sheath tumours identifies miR-29c as a tumour suppressor gene involved in tumour progression. | Programming of Schwann Cells by Lats1/2-TAZ/YAP Signaling Drives Malignant Peripheral Nerve Sheath Tumorigenesis. | Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment. | Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy. | A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors. | KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors. | Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance.,,"The SNF96.2 (CRL-2884, RRID: CVCL_K281) human MPNST cell line and the HEK-293T (CRL-3216, RRID: CVCL_0063) cell line were obtained from ATCC | The human MPNST cell line sNF96.2, was kindly provided by Dr Abhijit Guha...We confirmed the reported germline mutation in exon 21 (3683delC) | Human MPNST cell lines SNF02.2 and SNF96.2 were propagated in DMEM/10% FBS plus L-glutamine and penicillin/streptomycin | sNF96.2 (a MPNST cell line derived from a patient with NF1, used as target cells) | NF1-associated MPNST cells (sNF96.2, ATCC; MPNST642, MD Anderson; T265, A. Harder) | STS-26T (19), HS-PSS, HS-sch2 (20), S462 (21), and sNF96.2 (22) cell lines were previously established in other laboratories. | sNF96.2 (provided by Dr Thomas De Raedt) | Patient-derived neurofibroma (NF95.11b, NF95.6) or MPNST (SNF02.2, SNF94.3, SNF96.2, ST88-14) cell lines",0.95,Accept,Experimental Usage
RESa3b8883e,M1,Nerve,Peripheral nerve sheath,Malignant Peripheral Nerve Sheath Tumor,Neurofibromatosis Type 1,Cancer cell line,,,,,,,M1,PMID:39269317 | PMID:35789380,10.1158/1078-0432.CCR-24-1750 | 10.1158/2159-8290.CD-21-1671,MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath Tumor. | PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.,,"The M1, M3, M4, M5, and M6 human NF1-associated MPNST cell lines were gifted by Drs. William L. Gerald and Xiaoliang L. Xu | NF1 patient-derived human MPNST cell lines M1, M3, M4, and M6 were kind gifts developed by William L. Gerald and Xiaoliang L. Xu at Memorial Sloan Kettering Cancer Center",0.95,Accept,Experimental Usage
RESdc69ceb0,M3,Nerve,Peripheral nerve sheath,Malignant Peripheral Nerve Sheath Tumor,Neurofibromatosis Type 1,Cancer cell line,,,,,,,M3,PMID:39269317 | PMID:35789380,10.1158/1078-0432.CCR-24-1750 | 10.1158/2159-8290.CD-21-1671,MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath Tumor. | PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.,,"The M1, M3, M4, M5, and M6 human NF1-associated MPNST cell lines were gifted by Drs. William L. Gerald and Xiaoliang L. Xu | NF1 patient-derived human MPNST cell lines M1, M3, M4, and M6 were kind gifts developed by William L. Gerald and Xiaoliang L. Xu at Memorial Sloan Kettering Cancer Center",0.95,Accept,Experimental Usage
RESd9806b0b,M4,Nerve,Peripheral nerve sheath,Malignant Peripheral Nerve Sheath Tumor,Neurofibromatosis Type 1,Cancer cell line,,,,,,,M4,PMID:39269317 | PMID:35789380,10.1158/1078-0432.CCR-24-1750 | 10.1158/2159-8290.CD-21-1671,MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath Tumor. | PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.,,"The M1, M3, M4, M5, and M6 human NF1-associated MPNST cell lines were gifted by Drs. William L. Gerald and Xiaoliang L. Xu | NF1 patient-derived human MPNST cell lines M1, M3, M4, and M6 were kind gifts developed by William L. Gerald and Xiaoliang L. Xu at Memorial Sloan Kettering Cancer Center",0.95,Accept,Experimental Usage
RESa330fc30,M5,Nerve,Peripheral nerve sheath,Malignant Peripheral Nerve Sheath Tumor,Neurofibromatosis Type 1,Cancer cell line,,,,,,,M5,PMID:39269317,10.1158/1078-0432.CCR-24-1750,MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath Tumor.,,"The M1, M3, M4, M5, and M6 human NF1-associated MPNST cell lines were gifted by Drs. William L. Gerald and Xiaoliang L. Xu",0.95,Accept,Experimental Usage
RES15880533,M6,Nerve,Peripheral nerve sheath,Malignant Peripheral Nerve Sheath Tumor,Neurofibromatosis Type 1,Cancer cell line,,,,,,,M6,PMID:39269317 | PMID:35789380,10.1158/1078-0432.CCR-24-1750 | 10.1158/2159-8290.CD-21-1671,MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath Tumor. | PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.,,"The M1, M3, M4, M5, and M6 human NF1-associated MPNST cell lines were gifted by Drs. William L. Gerald and Xiaoliang L. Xu | NF1 patient-derived human MPNST cell lines M1, M3, M4, and M6 were kind gifts developed by William L. Gerald and Xiaoliang L. Xu at Memorial Sloan Kettering Cancer Center",0.95,Accept,Experimental Usage
RES65662a6d,Drosophila Schneider (S2R+) cells,Nerve,,,,Finite cell line,,,,,,,Drosophila Schneider (S2R+),PMID:39129390,10.1002/1878-0261.13704,Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors.,,"Drosophila Schneider (S2R+) cells, both WT and dNF1‐KO, were cultured at 25 °C in Schneider's media",0.9,Accept,Experimental Usage
REScd43134d,dNF1‐KO,Nerve,,,Neurofibromatosis Type 1,Finite cell line,,,,,,,dNF1‐KO,PMID:39129390,10.1002/1878-0261.13704,Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors.,,The dNF1‐KO cell line was generated using methods described previously,0.95,Accept,Development
RES2fe12b13,hTERT ipn02.3 2λ CRL‐3392,Nerve,Peripheral nerve sheath,,,Finite cell line,,,,,,,hTERT ipn02.3 2λ CRL‐3392,PMID:39129390,10.1002/1878-0261.13704,Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors.,,"NF1 and +/− NF1 immortalized human Schwann cell (SC) lines, derived from the ipn02.3 2λ (hTERT ipn02.3 2λ CRL‐3392) cell line",0.9,Accept,Experimental Usage
RES5e08b0cc,"ipnNF09.4 (hTERT NF1 ipnNF09.4, RRID: CVCL_UI73)",Nerve,Peripheral nerve sheath,Plexiform Neurofibroma,Neurofibromatosis Type 1,Finite cell line,,,,,,,"ipnNF09.4 (hTERT NF1 ipnNF09.4, RRID: CVCL_UI73)",PMID:39129390,10.1002/1878-0261.13704,Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors.,,"ipnNF09.4 (hTERT NF1 ipnNF09.4, RRID: CVCL_UI73; NF1 −/− ) and ipNF05.5",0.95,Accept,Experimental Usage
RES5de742ed,"ipNF05.5 (hTERT NF1 ipNF05.5, RRID: CVCL_UI71)",Nerve,Peripheral nerve sheath,Plexiform Neurofibroma,Neurofibromatosis Type 1,Finite cell line,,,,,,,"ipNF05.5 (hTERT NF1 ipNF05.5, RRID: CVCL_UI71)",PMID:39129390 | PMID:40862755 | PMID:39061138 | PMID:33658640,10.1002/1878-0261.13704 | 10.3390/cells14161276 | 10.3390/cancers16142498 | 10.1038/s41416-021-01270-8,Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors. | Fibroblasts Attenuate Anti-Tumor Drug Efficacy in Tumor Cells via Paracrine Interactions with Tumor Cells in 3D Plexiform Neurofibroma Cultures. | A Fibroblast-Derived Secretome Stimulates the Growth and Invasiveness of 3D Plexiform Neurofibroma Spheroids. | Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours.,,"ipNF05.5 (hTERT NF1 ipNF05.5, RRID: CVCL_UI71; +/− NF1 ) cells | The following immortalized human plexiform neurofibroma cell lines (Nf1−/−; hereafter called pNF1 cells) described in [23] were used: ipNF95.11b C and ipNF05.5 purchased from ATCC. | The following immortalized human plexiform neurofibroma cell lines (hereafter called pNF1 cells) described in [ 36 ] were used: ipNF95.11b C, ipNF95.11b C-RFP, and ipNF 05.5 | Immortalised human Schwann cell lines with mutant NF1 (ipNF05.5 and 95.6) and wt NF1 (ipn02.3)",0.95,Accept,Experimental Usage
RES0242f8da,U2OS,Bone,Osteosarcoma,Osteosarcoma,,Cancer cell line,,,,,,,U2OS,PMID:30531922,10.1038/s41591-018-0263-8,The molecular landscape of glioma in patients with Neurofibromatosis 1.,,standard curves for quantitative analysis were prepared with serially diluted QuickPreps of ALT[+] U2OS and ALT[-] HEK293 cell lines,0.85,Accept,Experimental Usage
RES35bbc5c9,Human meningeal cells (HMC),Brain,Meninges,,,Finite cell line,,,,,,,Human meningeal cells (HMC),PMID:28126595,10.1016/j.ebiom.2017.01.020,Global Proteome and Phospho-proteome Analysis of Merlin-deficient Meningioma and Schwannoma Identifies PDLIM2 as a Novel Therapeutic Target.,,Human meningeal cells (HMC) were obtained from Sciencell™ and maintained in the manufacturer's recommended media at 5% CO2.,0.85,Accept,Experimental Usage
RESb9449add,lymphoblastoid cell lines,Blood,Peripheral white blood cells,,Neurofibromatosis Type 1,Finite cell line,,,,,,,lymphoblastoid,PMID:25329635,10.1371/journal.pgen.1004575,Genetic modifiers of neurofibromatosis type 1-associated café-au-lait macule count identified using multi-platform analysis.,,"Lymphoblastoid cell lines (LCLs) from the first 79 participants (""EXPR"") were used in the gene expression screen to identify putative modifiers.",0.85,Accept,Experimental Usage
RES33b4d8cc,OLN93 mouse oligodendrocyte cell line,Brain,Oligodendrocyte,,,Finite cell line,,,,,,,OLN93 mouse oligodendrocyte,PMID:29715273,10.1371/journal.pone.0196726,Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation.,,"OLN93 mouse oligodendrocyte cell line was kindly provided by Dr. C. Richter-Landsberg (Oldenburg University, Germany)",0.9,Accept,Experimental Usage
RES4bb1d196,SC4-immortalized Nf2-/- primary Schwann cells,Nerve,Schwann cells,,Neurofibromatosis Type 2,Finite cell line,,,,,,,SC4-immortalized Nf2-/- primary Schwann,PMID:29715273,10.1371/journal.pone.0196726,Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation.,,SC4-immortalized Nf2-/- primary Schwann cells were derived from Nf2-/- deficient mice,0.95,Accept,Experimental Usage
RESc23eadf1,RT4-D6PT2 schwannoma cell line,Nerve,Peripheral nerve,Schwannoma,,Cancer cell line,,,,,,,RT4-D6PT2 schwannoma,PMID:29715273,10.1371/journal.pone.0196726,Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation.,,The RT4-D6PT2 schwannoma cell line was obtained from the European Collection of Animal Cell Cultures,0.9,Accept,Experimental Usage
RES6b2e8a99,TC620 human oligodendroglioma cell line,Brain,Oligodendrocyte,Oligodendroglioma,,Cancer cell line,,,,,,,TC620 human oligodendroglioma,PMID:29715273,10.1371/journal.pone.0196726,Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation.,,The TC620 human oligodendroglioma cell line was a gift from Dr. A. Glassmann,0.9,Accept,Experimental Usage
RESb2bfc67f,Normal human Schwann cells (NHSC),Nerve,Peripheral nerve,,,Finite cell line,,,,,,,Normal human Schwann cells (NHSC),PMID:24509877,10.1038/onc.2013.506,MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1.,,Normal human Schwann cells (NHSC) from trauma victims and MPNST cell lines were cultured as described,0.85,Accept,Experimental Usage
RES8bfa4d28,MPNST cell lines,Nerve,Peripheral nerve sheath,Malignant Peripheral Nerve Sheath Tumor,Neurofibromatosis Type 1,Cancer cell line,,,,,,,MPNST,PMID:24509877 | PMID:18413802,10.1038/onc.2013.506 | 10.1158/1535-7163.MCT-07-0518,MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1. | Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells.,,Normal human Schwann cells (NHSC) from trauma victims and MPNST cell lines were cultured as described | MPNST was derived from a patient with a high grade peripheral nerve sheath tumor of the thigh,0.9,Accept,Experimental Usage
RES8fea907c,MPNST 88-14 cells,Nerve,Peripheral nerve sheath,Malignant Peripheral Nerve Sheath Tumor,Neurofibromatosis Type 1,Cancer cell line,,,,,,,MPNST 88-14,PMID:24509877,10.1038/onc.2013.506,MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1.,,MPNST 88-14 cells were cross-linked with 1% formaldehyde for 10 minutes on ice,0.95,Accept,Experimental Usage
RES6703798b,MPNST S462-TY cells,Nerve,Peripheral nerve sheath,Malignant Peripheral Nerve Sheath Tumor,Neurofibromatosis Type 1,Cancer cell line,,,,,,,MPNST S462-TY,PMID:24509877,10.1038/onc.2013.506,MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1.,,1.5 ×10 6 MPNST S462-TY cells suspended in Matrigel (BD) and expressing pLVX control or inducible-MAF were injected subcutaneously,0.95,Accept,Experimental Usage
RES08493b1a,2884 cell line,Nerve,Peripheral nerve sheath,Malignant Peripheral Nerve Sheath Tumor,Neurofibromatosis Type 1,Cancer cell line,,,,,,,2884,PMID:23328114,10.18632/oncotarget.793,Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition.,,cells were seeded at 1.0 × 104 (S462 cell-line) or 3.0 × 104 (2884 and 2885 cell-lines) cells/well,0.9,Accept,Experimental Usage
RES9228949e,2885 cell line,Nerve,Peripheral nerve sheath,Malignant Peripheral Nerve Sheath Tumor,Neurofibromatosis Type 1,Cancer cell line,,,,,,,2885,PMID:23328114,10.18632/oncotarget.793,Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition.,,cells were seeded at 1.0 × 104 (S462 cell-line) or 3.0 × 104 (2884 and 2885 cell-lines) cells/well,0.9,Accept,Experimental Usage
RESa4c9d0d2,hTERT NF1 ipn02.3 2λ,Nerve,Peripheral nerve sheath,,Neurofibromatosis Type 1,Finite cell line,,,,,,,hTERT NF1 ipn02.3 2λ,PMID:36322658,10.1126/sciadv.abo5442,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.,,"Immortalized SCs (hTERT NF1 ipn02.3 2λ, M. Wallace), NF cells [ipn95.11bC, American Type Culture Collection (ATCC)",0.9,Accept,Experimental Usage
RESc11f75a8,ipn95.11bC,Nerve,Peripheral nerve sheath,Neurofibroma,Neurofibromatosis Type 1,Cancer cell line,,,,,,,ipn95.11bC,PMID:36322658,10.1126/sciadv.abo5442,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.,,"NF cells [ipn95.11bC, American Type Culture Collection (ATCC): Neurofibromatosis Therapeutic Acceleration Program (NTAP)]",0.9,Accept,Experimental Usage
RESfc99283a,MPNST642,Nerve,Peripheral nerve sheath,Malignant Peripheral Nerve Sheath Tumor,Neurofibromatosis Type 1,Cancer cell line,,,,,,,MPNST642,PMID:36322658,10.1126/sciadv.abo5442,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.,,"NF1-associated MPNST cells (sNF96.2, ATCC; MPNST642, MD Anderson; T265, A. Harder)",0.9,Accept,Experimental Usage
RES46d7227b,T265,Nerve,Peripheral nerve sheath,Malignant Peripheral Nerve Sheath Tumor,Neurofibromatosis Type 1,Cancer cell line,,,,,,,T265,PMID:36322658 | PMID:37164978 | PMID:24681606 | PMID:23685747 | PMID:30055648 | PMID:41001593 | PMID:38203448 | PMID:32948135 | PMID:23535903,10.1126/sciadv.abo5442 | 10.1038/s41467-023-38432-6 | 10.18632/oncotarget.1609 | 10.1038/ng.2641 | 10.1186/s13104-018-3630-0 | 10.1080/23723556.2025.2561292 | 10.3390/ijms25010277 | 10.1186/s12885-020-07397-w | 10.1158/2159-8290.CD-13-0081,"Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy. | Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities. | Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity. | Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis. | Testing ATRA and MEK inhibitor PD0325901 effectiveness in a nude mouse model for human MPNST xenografts. | Loss of Schwann cell's normal rhythmic core clock gene expression and gain of rhythmic expression of oncogenic driver genes in malignant NF1-associated peripheral nerve sheath tumor. | FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells. | Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model. | Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance.",,"NF1-associated MPNST cells (sNF96.2, ATCC; MPNST642, MD Anderson; T265, A. Harder) | MPNST cell lines (STS-26T, S462, S462TY, T265) were obtained from Dr. David Largaespada's laboratory | Immortalized human Schwann cell and MPNST cell lines (S462 [ 34 ], S462-TY [ 35 ], ST8814 [ 36 ], T265 [ 37 ], and STS-26T [ 38 ]) | human MPNST cell lines (ST88-14, STS26T, S462, S462-TY, and T265) | Human MPNST cell lines S462 and T265 were described previously...NF1 associated MPNST derived from S462 but not T265 cells form solid subcutaneous tumors | Human T265, S462, and NSF1 cell lines of malignant peripheral nerve sheath tumors (MPNSTs) being associated with neurofibromatosis type 1 | The MPNST cell lines STS26T, T265, and ST8814 have been reported before and were gifted by Dr. Nancy Ratner | Human MPNST cell lines (S462, T265, and NSF1) were analyzed and have been described in detail in our previous studies | Immortalized human Schwann cell and MPNST cell lines (S462 ( 45 ), S462-TY ( 35 ), ST8814 ( 46 ), T265 ( 47 ), and STS-26T ( 36 ))",0.9,Accept,Experimental Usage
RES74567322,STS26T,Nerve,Peripheral nerve sheath,Malignant Peripheral Nerve Sheath Tumor,,Cancer cell line,,,,,,,STS26T,PMID:36322658 | PMID:37164978 | PMID:24681606 | PMID:23685747 | PMID:20049725 | PMID:32642733 | PMID:18483311 | PMID:38203448 | PMID:37410426 | PMID:23535903 | PMID:35511749 | PMID:33032988,10.1126/sciadv.abo5442 | 10.1038/s41467-023-38432-6 | 10.18632/oncotarget.1609 | 10.1038/ng.2641 | 10.1002/emmm.200900027 | 10.1093/noajnl/vdz061 | 10.1158/1535-7163.MCT-07-2335 | 10.3390/ijms25010277 | 10.1158/1078-0432.CCR-23-0749 | 10.1158/2159-8290.CD-13-0081 | 10.1158/1535-7163.MCT-21-0947 | 10.1158/0008-5472.CAN-20-1365,"Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy. | Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities. | Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity. | Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis. | Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene. | KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors. | Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors. | FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells. | CDK4/6-MEK Inhibition in MPNSTs Causes Plasma Cell Infiltration, Sensitization to PD-L1 Blockade, and Tumor Regression. | Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance. | A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors. | Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.",,"sporadic MPNST cells (STS26T, D. Scoles) were seeded on poly-l-lysine–coated 12-mm circle glass coverslips | MPNST cell lines (STS-26T, S462, S462TY, T265) were obtained from Dr. David Largaespada's laboratory | Immortalized human Schwann cell and MPNST cell lines (S462 [ 34 ], S462-TY [ 35 ], ST8814 [ 36 ], T265 [ 37 ], and STS-26T [ 38 ]) | human MPNST cell lines (ST88-14, STS26T, S462, S462-TY, and T265) | We maintained MPNST cell lines ST88-14, STS26T, S520, S462, 88-3, 90-8 and YST1 | 90-8 and the sporadic MPNST-derived STS-26T (provided by Dr Eric Legius) | MPNST cell lines STS26T, ST8814, ST88-3 S462, T265p21, S520, 90–8, and YST1...All cell lines were from NF1 patients except YST-1 and STS26T | The MPNST cell lines STS26T, T265, and ST8814 have been reported before and were gifted by Dr. Nancy Ratner | Authenticated human MPNST cell lines (sporadic STS26T, called 26T, Cellosaurus RRID: CVCL_8917 | Immortalized human Schwann cell and MPNST cell lines (S462 ( 45 ), S462-TY ( 35 ), ST8814 ( 46 ), T265 ( 47 ), and STS-26T ( 36 )) | STS-26T (19), HS-PSS, HS-sch2 (20), S462 (21), and sNF96.2 (22) cell lines were previously established in other laboratories. | STS26T, ST8814 and NF90.8 were kindly provided by Dr. Gregory Riggins at Johns Hopkins University",0.9,Accept,Experimental Usage
RES5718db6a,ipn97.4 immortalized human Schwann cells,Nerve,Schwann cells,,Neurofibromatosis Type 1,Finite cell line,,,,,,,ipn97.4 immortalized human Schwann,PMID:39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,,"ipn97.4 immortalized human Schwann cells were obtained from Peggy Wallace. To create an isogenic NF1 null cell line, we utilized CRISPR Cas9 targeting...",0.9,Accept,Experimental Usage
RES4bc847e6,Schwann cells,Nerve,Peripheral nerve sheath,,Neurofibromatosis Type 1,Finite cell line,,,,,,,Schwann,PMID:37520682,10.1016/j.omtn.2023.06.018,Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1.,,Schwann cells were isolated as previously described. Sciatic nerve or cutaneous neurofibroma were biopsied from WT or NF1 R1947/+ minipigs,0.9,Accept,Experimental Usage
RES5ca9707b,optic glioma cells,Nerve,Optic nerve,Optic Nerve Glioma,Neurofibromatosis Type 1,Cancer cell line,,,,,,,optic glioma,PMID:34040258,10.1038/s41586-021-03580-6,NF1 mutation drives neuronal activity-dependent initiation of optic glioma.,,Optic glioma cells were isolated from the optic nerves of three-month-old Nf1OPG mice,0.8,Accept,Experimental Usage
RESaed6fdb0,HSC1λ,Nerve,Peripheral nerve sheath,,,Finite cell line,,,,,,,HSC1λ,PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,Immortalized human Schwann cell (HSC1λ) and immortalized neurofibroma cell (ipNF06.2A) were obtained from Dr. Margaret Wallace's laboratory,0.9,Accept,Experimental Usage
RES2d65bb8e,ipNF06.2A,Nerve,Peripheral nerve sheath,Neurofibroma,Neurofibromatosis Type 1,Finite cell line,,,,,,,ipNF06.2A,PMID:37164978 | PMID:38136356,10.1038/s41467-023-38432-6 | 10.3390/cancers15245811,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities. | Drug Responses in Plexiform Neurofibroma Type I (PNF1) Cell Lines Using High-Throughput Data and Combined Effectiveness and Potency.,,"Immortalized human Schwann cell (HSC1λ) and immortalized neurofibroma cell (ipNF06.2A) were obtained from Dr. Margaret Wallace's laboratory | ...NF1 −/− plexiform neurofibroma cell lines (PNF1 cells) ipNF05.5-MX, ipNF06.2A, ipNF95.11b C/T, and ipNF95.6 as test lines...",0.9,Accept,Experimental Usage
RES1de4e591,HeLa cells,Cervix,,,,Cancer cell line,,,,,,,HeLa,PMID:40590220 | PMID:36420221 | PMID:32383545,10.1172/JCI188932 | 10.1016/j.omtn.2022.10.026 | 10.15252/embr.201949117,A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice. | Antisense oligonucleotides targeting exon 11 are able to partially rescue the NF2-related schwannomatosis phenotype | Hexokinase 2 displacement from mitochondria-associated membranes prompts Ca,,"HeLa cells (ATCC CCL-2) | The expression vector was transfected into HeLa cells (Lipofectamine LTX with Plus Reagent, Invitrogen) | Human cervix carcinoma HeLa cells, human breast cancer MDA‐MB‐231 cells, human malignant peripheral nerve sheath tumor S462 cells",0.95,Accept,Experimental Usage
RES27fb92bc,C2C12 cells,Muscle,Skeletal muscle,,,Finite cell line,,,,,,,C2C12,PMID:32383545 | PMID:37446790,10.15252/embr.201949117 | 10.3390/molecules28135128,Hexokinase 2 displacement from mitochondria-associated membranes prompts Ca | Icariin Promotes Osteogenic Differentiation in a Cell Model with NF1 Gene Knockout by Activating the cAMP/PKA/CREB Pathway.,,mouse myoblast C2C12 cells were cultured in DMEM medium | The C2C12 line is a subclone of a mouse myoblast cell line. These cells were purchased from the American Type Culture Collection (ATCC),0.85,Accept,Experimental Usage
REScb018edb,NF1-1 hiPSC line,Blood,,,Neurofibromatosis Type 1,Embryonic stem cell,,,,,,,NF1-1 hiPSC line,PMID:38481529,10.3389/fcell.2024.1359561,Generation of heterozygous and homozygous NF1 lines from human-induced pluripotent stem cells using CRISPR/Cas9 to investigate bone defects associated with neurofibromatosis type 1.,,NF1-1 and NF1-2 hiPSC lines were reprogrammed using OSKM episomal technique by Phenocell from two patient-derived fibroblasts carrying NF1 mutations,0.9,Accept,Experimental Usage
RES44e8d8f6,NF1-2 hiPSC line,Blood,,,Neurofibromatosis Type 1,Embryonic stem cell,,,,,,,NF1-2 hiPSC line,PMID:38481529,10.3389/fcell.2024.1359561,Generation of heterozygous and homozygous NF1 lines from human-induced pluripotent stem cells using CRISPR/Cas9 to investigate bone defects associated with neurofibromatosis type 1.,,NF1-1 and NF1-2 hiPSC lines were reprogrammed using OSKM episomal technique by Phenocell from two patient-derived fibroblasts carrying NF1 mutations,0.9,Accept,Experimental Usage
RES71ae386c,WT-1 hiPSC line,Blood,,,,Embryonic stem cell,,,,,,,WT-1 hiPSC line,PMID:38481529,10.3389/fcell.2024.1359561,Generation of heterozygous and homozygous NF1 lines from human-induced pluripotent stem cells using CRISPR/Cas9 to investigate bone defects associated with neurofibromatosis type 1.,,Two control NF1 (+/+) hiPSC lines (WT-1 and WT-2) purchased from Phenocell were also generated from control donors,0.85,Accept,Experimental Usage
RES637f1fbc,WT-2 hiPSC line,Blood,,,,Embryonic stem cell,,,,,,,WT-2 hiPSC line,PMID:38481529,10.3389/fcell.2024.1359561,Generation of heterozygous and homozygous NF1 lines from human-induced pluripotent stem cells using CRISPR/Cas9 to investigate bone defects associated with neurofibromatosis type 1.,,Two control NF1 (+/+) hiPSC lines (WT-1 and WT-2) purchased from Phenocell were also generated from control donors,0.85,Accept,Experimental Usage
RESbb2011d5,LUVA cells,Nerve,,,Neurofibromatosis Type 1,Cancer cell line,,,,,,,LUVA,PMID:40590220,10.1172/JCI188932,A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice.,,LUVA cells (Kerafast) were cultured in STEM PRO-34 SFM,0.85,Accept,Experimental Usage
RES8ff373eb,"Human Schwann Cells (HSC, ScienCell Research Laboratories #1700)",Nerve,Peripheral nerve,,,Finite cell line,,,,,,,"Human Schwann Cells (HSC, ScienCell Research Laboratories #1700)",PMID:38216587,10.1038/s41467-023-40408-5,Epigenetic reprogramming shapes the cellular landscape of schwannoma.,,"Human Schwann cells (HSC, ScienCell Research Laboratories #1700) and Mouse Schwann Cells (MSC, ScienCell Research Laboratories #M1700-57) were cultured",0.9,Accept,Experimental Usage
RESeb9e3bd3,"Mouse Schwann Cells (MSC, ScienCell Research Laboratories #M1700-57)",Nerve,Peripheral nerve,,,Finite cell line,,,,,,,"Mouse Schwann Cells (MSC, ScienCell Research Laboratories #M1700-57)",PMID:38216587,10.1038/s41467-023-40408-5,Epigenetic reprogramming shapes the cellular landscape of schwannoma.,,"Human Schwann cells (HSC, ScienCell Research Laboratories #1700) and Mouse Schwann Cells (MSC, ScienCell Research Laboratories #M1700-57) were cultured",0.9,Accept,Experimental Usage
RESbaf0c6ad,NF37,Dental pulp,Dental pulp,,Neurofibromatosis Type 1,Finite cell line,,,,,,,NF37,PMID:29941005,10.1186/s13023-018-0843-1,Increased extracellular matrix deposition during chondrogenic differentiation of dental pulp stem cells from individuals with neurofibromatosis type 1: an in vitro 2D and 3D study.,,...Two primary cell cultures were obtained from individuals with NF1 (NF1 group; NF37 and NF87) and three from individuals without NF1...,0.85,Accept,Experimental Usage
RES4f830669,NF87,Dental pulp,Dental pulp,,Neurofibromatosis Type 1,Finite cell line,,,,,,,NF87,PMID:29941005,10.1186/s13023-018-0843-1,Increased extracellular matrix deposition during chondrogenic differentiation of dental pulp stem cells from individuals with neurofibromatosis type 1: an in vitro 2D and 3D study.,,...Two primary cell cultures were obtained from individuals with NF1 (NF1 group; NF37 and NF87) and three from individuals without NF1...,0.85,Accept,Experimental Usage
RES0bb17402,CT10,Dental pulp,Dental pulp,,,Finite cell line,,,,,,,CT10,PMID:29941005,10.1186/s13023-018-0843-1,Increased extracellular matrix deposition during chondrogenic differentiation of dental pulp stem cells from individuals with neurofibromatosis type 1: an in vitro 2D and 3D study.,,"...three from individuals without NF1 (control group; CT10, CT11 and CT12). Participants were both men and women...",0.85,Accept,Experimental Usage
RES2566bbac,CT11,Dental pulp,Dental pulp,,,Finite cell line,,,,,,,CT11,PMID:29941005,10.1186/s13023-018-0843-1,Increased extracellular matrix deposition during chondrogenic differentiation of dental pulp stem cells from individuals with neurofibromatosis type 1: an in vitro 2D and 3D study.,,"...three from individuals without NF1 (control group; CT10, CT11 and CT12). Participants were both men and women...",0.85,Accept,Experimental Usage
RESe416a28a,CT12,Dental pulp,Dental pulp,,,Finite cell line,,,,,,,CT12,PMID:29941005,10.1186/s13023-018-0843-1,Increased extracellular matrix deposition during chondrogenic differentiation of dental pulp stem cells from individuals with neurofibromatosis type 1: an in vitro 2D and 3D study.,,"...three from individuals without NF1 (control group; CT10, CT11 and CT12). Participants were both men and women...",0.85,Accept,Experimental Usage
RES359bb0bd,SNF02.2,Nerve,Peripheral nerve sheath,Malignant Peripheral Nerve Sheath Tumor,Neurofibromatosis Type 1,Cancer cell line,,,,,,,SNF02.2,PMID:29438698 | PMID:38216572,10.1016/j.ccell.2018.01.005 | 10.1038/s41467-024-44755-9,Programming of Schwann Cells by Lats1/2-TAZ/YAP Signaling Drives Malignant Peripheral Nerve Sheath Tumorigenesis. | Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance.,,"Human MPNST cell lines SNF02.2 and SNF96.2 were propagated in DMEM/10% FBS plus L-glutamine and penicillin/streptomycin | Patient-derived neurofibroma (NF95.11b, NF95.6) or MPNST (SNF02.2, SNF94.3, SNF96.2, ST88-14) cell lines",0.95,Accept,Experimental Usage
RES7b299c69,TM-31,Brain,High Grade Glioma,High Grade Glioma,Neurofibromatosis Type 1,Cancer cell line,,,,,,,TM-31,PMID:36730269,10.1371/journal.pone.0277305,Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas.,,"The NF1 patient-derived HGG cell line TM-31 (RRID:CVCL_6735), purchased from the RIKEN biorepository, is null for NF1, TP53, CDKN2A and ATRX",0.95,Accept,Experimental Usage
RESecb75ef8,LN319,Brain,Glioblastoma,Glioblastoma Multiforme,Neurofibromatosis Type 1,Cancer cell line,,,,,,,LN319,PMID:36730269,10.1371/journal.pone.0277305,Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas.,,The Glioblastoma Multiphorme (GBM) LN319 cell line was a gift from Dr. Karen Cichowski. LN319 is an adult sporadic GBM with full inactivation of NF1,0.9,Accept,Experimental Usage
RESa28a03a6,17,Brain,High Grade Glioma,High Grade Glioma,Neurofibromatosis Type 1,Cancer cell line,,,,,,,17,PMID:36730269,10.1371/journal.pone.0277305,Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas.,,"Mouse NF1-HGG cell lines 17, 5653, and 5746 were derived from three distinct high-grade murine brain tumors sporadically developed by the NPcis genetically engineered mouse model",0.95,Accept,Experimental Usage
RESa015d578,5653,Brain,High Grade Glioma,High Grade Glioma,Neurofibromatosis Type 1,Cancer cell line,,,,,,,5653,PMID:36730269,10.1371/journal.pone.0277305,Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas.,,"Mouse NF1-HGG cell lines 17, 5653, and 5746 were derived from three distinct high-grade murine brain tumors sporadically developed by the NPcis genetically engineered mouse model",0.95,Accept,Experimental Usage
RESe4bdb201,5746,Brain,High Grade Glioma,High Grade Glioma,Neurofibromatosis Type 1,Cancer cell line,,,,,,,5746,PMID:36730269,10.1371/journal.pone.0277305,Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas.,,"Mouse NF1-HGG cell lines 17, 5653, and 5746 were derived from three distinct high-grade murine brain tumors sporadically developed by the NPcis genetically engineered mouse model",0.95,Accept,Experimental Usage
RES2c34b788,"Human Schwann cells (HSC; ScienCell, Carlsbad, CA)",Nerve,Peripheral nerve,,,Finite cell line,,,,,,,"Human Schwann cells (HSC; ScienCell, Carlsbad, CA)",PMID:20195187,10.1097/MAO.0b013e3181d2777f,Merlin knockdown in human Schwann cells: clues to vestibular schwannoma tumorigenesis.,,"Human Schwann cells (HSC; ScienCell, Carlsbad, CA) were maintained in culture at 37°C in an atmosphere of 5% carbon dioxide.",0.9,Accept,Experimental Usage
RES310ed0e3,LS141,Soft tissue,Retroperitoneal,Dedifferentiated liposarcoma,,Cancer cell line,,,,,,,LS141,PMID:18413802,10.1158/1535-7163.MCT-07-0518,Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells.,,LS141 and DDLS primary human cell lines were derived from two patients with high grade retroperitoneal dedifferentiated liposarcoma,0.8,Accept,Experimental Usage
RES4ea34695,DDLS,Soft tissue,Retroperitoneal,Dedifferentiated liposarcoma,,Cancer cell line,,,,,,,DDLS,PMID:18413802,10.1158/1535-7163.MCT-07-0518,Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells.,,LS141 and DDLS primary human cell lines were derived from two patients with high grade retroperitoneal dedifferentiated liposarcoma,0.8,Accept,Experimental Usage
RESa6f1e455,Human Schwann cells (HSCs),Nerve,Peripheral nerve,,,Finite cell line,,,,,,,Human Schwann cells (HSCs),PMID:30274821,10.1016/j.ebiom.2018.09.042,Synergistic effect of Nutlin-3 combined with MG-132 on schwannoma cells through restoration of merlin and p53 tumour suppressors.,,"Human Schwann cells (HSCs) were purchased from ScienCell Research Laboratories (catalog no., 1700).",0.85,Accept,Experimental Usage
RES8053683d,RT4-D6P2T schwannoma cells,Nerve,Peripheral nerve sheath,Schwannoma,Neurofibromatosis Type 2,Cancer cell line,,,,,,,RT4-D6P2T schwannoma,PMID:30274821,10.1016/j.ebiom.2018.09.042,Synergistic effect of Nutlin-3 combined with MG-132 on schwannoma cells through restoration of merlin and p53 tumour suppressors.,,The rat RT4-D6P2T schwannoma cells was obtained from the Global Bioresource Center.,0.9,Accept,Experimental Usage
RES6e47acf7,LN428 human glioblastoma multiforme (GBM) cell line,Brain,Brain,Glioblastoma multiforme,,Cancer cell line,,,,,,,LN428 human glioblastoma multiforme (GBM),PMID:20554030,10.1016/j.jneuroim.2010.05.002,CXCL12 alone is insufficient for gliomagenesis in Nf1 mutant mice.,,LN428 human glioblastoma multiforme (GBM) cell line was a gift from Dr. Erwin van Meir,0.85,Accept,Experimental Usage
RES30a714b9,BL21(DE3) Star,Bacterial,,,,Finite cell line,,,,,,,BL21(DE3) Star,PMID:28831766,10.1007/s12104-017-9768-1,NMR resonance assignments of the EVH1 domain of neurofibromin's recruitment factor Spred1.,,The plasmid was transformed into the E. coli strain BL21(DE3) Star (Invitrogen),0.9,Accept,Experimental Usage
REScc45049c,NF1-null 293T cells,Kidney,Embryonic kidney,NF1 knockout,Neurofibromatosis Type 1,Cancer cell line,,,,,,,NF1-null 293T,PMID:36689660,10.1073/pnas.2208960120,Destabilizing NF1 variants act in a dominant negative manner through neurofibromin dimerization.,,Generation of NF1-null 293T cells has been previously described (12).,0.85,Accept,Experimental Usage
RES2ab2c141,mouse embryonic fibroblasts (MEFs),Embryo,Embryonic fibroblasts,,,Finite cell line,,,,,,,mouse embryonic fibroblasts (MEFs),PMID:28392281 | PMID:34065204,10.1016/j.expneurol.2017.04.001 | 10.3390/ijms22105367,Human stem cell modeling in neurofibromatosis type 1 (NF1). | RABL6A Regulates Schwann Cell Senescence in an RB1-Dependent Manner.,,The first direct lineage conversion of post-mitotic neurons from mouse embryonic fibroblasts (MEFs) and tail-tip fibroblasts (TTFs) | Mouse embryonic fibroblasts (MEFs) from wildtype and Rabl6m/m C57Bl/6N mice were isolated and cultured,0.9,Accept,Experimental Usage
RES06bbbd46,JH-2-002,Nerve,Peripheral nerve sheath,Malignant Peripheral Nerve Sheath Tumor,Neurofibromatosis Type 1,Cancer cell line,,,,,,,JH-2-002,PMID:38000020 | PMID:38127282,10.1126/sciadv.adg8876 | 10.1158/1078-0432.CCR-23-2548,CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors. | Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,"Four patient-derived NF1-MPNST cell lines (JH-2-002, JH-2-031, JH-2-079c, and JH-2-103) were generated in our laboratories | Human MPNST cell lines JH-2–002 were obtained from the Johns Hopkins NF1 Biospecimen Repository",0.9,Accept,Experimental Usage
RES748525c7,JH-2-031,Nerve,Peripheral nerve sheath,Malignant Peripheral Nerve Sheath Tumor,Neurofibromatosis Type 1,Cancer cell line,,,,,,,JH-2-031,PMID:38000020,10.1126/sciadv.adg8876,CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.,,"Four patient-derived NF1-MPNST cell lines (JH-2-002, JH-2-031, JH-2-079c, and JH-2-103) were generated in our laboratories",0.9,Accept,Experimental Usage
RES24aca845,JH-2-079c,Nerve,Peripheral nerve sheath,Malignant Peripheral Nerve Sheath Tumor,Neurofibromatosis Type 1,Cancer cell line,,,,,,,JH-2-079c,PMID:38000020,10.1126/sciadv.adg8876,CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.,,"Four patient-derived NF1-MPNST cell lines (JH-2-002, JH-2-031, JH-2-079c, and JH-2-103) were generated in our laboratories",0.9,Accept,Experimental Usage
RES76c34922,JH-2-103,Nerve,Peripheral nerve sheath,Malignant Peripheral Nerve Sheath Tumor,Neurofibromatosis Type 1,Cancer cell line,,,,,,,JH-2-103,PMID:38000020 | PMID:38127282,10.1126/sciadv.adg8876 | 10.1158/1078-0432.CCR-23-2548,CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors. | Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,"Four patient-derived NF1-MPNST cell lines (JH-2-002, JH-2-031, JH-2-079c, and JH-2-103) were generated in our laboratories | Human MPNST cell lines JH-2–103 were obtained from the Johns Hopkins NF1 Biospecimen Repository",0.9,Accept,Experimental Usage
RES9da57d39,iHSCs,Nerve,Peripheral nerve,,,Finite cell line,,,,,,,iHSCs,PMID:23685747 | PMID:41036607,10.1038/ng.2641 | 10.1158/1535-7163.MCT-24-1053,Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis. | Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors.,,Immortalized human Schwann cells (iHSCs) were acquired from the laboratory of Dr. Margaret Wallace | iHSC lines were maintained and passaged at 37°C with 5% CO2 in DMEM high-glucose media supplemented with 10% FBS and penicillin/streptomycin,0.9,Accept,Experimental Usage
RESfdd6b370,K562,Blood,Bone marrow,,,Cancer cell line,,,,,,,K562,PMID:23685747 | PMID:40025578,10.1038/ng.2641 | 10.1186/s40478-025-01965-6,Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis. | Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment.,,"Assembled TALENs were tested by transient transfection into K562 cells | K562 (a chronic myelogenous leukemia cell line, used as target cells)",0.8,Accept,Experimental Usage
RES6156e612,icNF97.2a,Nerve,Cutaneous neurofibroma,Cutaneous neurofibroma,Neurofibromatosis Type 1,Finite cell line,,,,,,,icNF97.2a,PMID:41564118 | PMID:38907342,10.1371/journal.pone.0340183 | 10.1186/s40478-024-01821-z,"Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas. | snRNA-seq of human cutaneous neurofibromas before and after selumetinib treatment implicates role of altered Schwann cell states, inter-cellular signaling, and extracellular matrix in treatment response.",,"immortalized cNF cell lines through transduction with wild-type human telomerase reverse transcriptase (hTERT) and murine cyclin-dependent kinase 4 (mCdk4) genes | Immortalized cutaneous neurofibroma Schwann cell lines (icNF 97.2a, icNF 97.2b, and icNF 98.4d) were obtained from Dr. Margaret Wallace",0.95,Accept,Development
RESe3697125,icNF97.2b,Nerve,Cutaneous neurofibroma,Cutaneous neurofibroma,Neurofibromatosis Type 1,Finite cell line,,,,,,,icNF97.2b,PMID:41564118 | PMID:38907342,10.1371/journal.pone.0340183 | 10.1186/s40478-024-01821-z,"Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas. | snRNA-seq of human cutaneous neurofibromas before and after selumetinib treatment implicates role of altered Schwann cell states, inter-cellular signaling, and extracellular matrix in treatment response.",,"immortalized cNF cell lines through transduction with wild-type human telomerase reverse transcriptase (hTERT) and murine cyclin-dependent kinase 4 (mCdk4) genes | Immortalized cutaneous neurofibroma Schwann cell lines (icNF 97.2a, icNF 97.2b, and icNF 98.4d) were obtained from Dr. Margaret Wallace",0.95,Accept,Development
RES0583d402,icNF98.4d,Nerve,Cutaneous neurofibroma,Cutaneous neurofibroma,Neurofibromatosis Type 1,Finite cell line,,,,,,,icNF98.4d,PMID:41564118 | PMID:38907342,10.1371/journal.pone.0340183 | 10.1186/s40478-024-01821-z,"Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas. | snRNA-seq of human cutaneous neurofibromas before and after selumetinib treatment implicates role of altered Schwann cell states, inter-cellular signaling, and extracellular matrix in treatment response.",,"immortalized cNF cell lines through transduction with wild-type human telomerase reverse transcriptase (hTERT) and murine cyclin-dependent kinase 4 (mCdk4) genes | Immortalized cutaneous neurofibroma Schwann cell lines (icNF 97.2a, icNF 97.2b, and icNF 98.4d) were obtained from Dr. Margaret Wallace",0.95,Accept,Development
RES63f2af1e,293T cells,Kidney,Embryonic kidney,,,Cancer cell line,,,,,,,293T,PMID:40025578 | PMID:25026211 | PMID:26219339,10.1186/s40478-025-01965-6 | 10.1016/j.ccr.2014.05.001 | 10.18632/oncotarget.4858,Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment. | Merlin/NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the hippo pathway kinases Lats1 and 2 in the nucleus. | A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas.,,"Human 293T cells (used for lentiviral packaging), sNF96.2 (a MPNST cell line derived from a patient with NF1, used as target cells) | FH-DCAF1 and FH-Lats1 (purified from 293T cells) were incubated in 20 μl reaction buffer | Low passage 293T cells for large-scale lentiviral packaging were obtained from TRC",0.85,Accept,Experimental Usage
RESd6afe7f8,HFFs,Skin,Foreskin,,,Finite cell line,,,,,,,HFFs,PMID:40025578,10.1186/s40478-025-01965-6,Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment.,,"HFFs (human foreskin fibroblasts, used as target cells) were maintained in DMEM",0.8,Accept,Experimental Usage
RES32251ebd,NCI-H266,Lung,Lung,Lung carcinoma,,Cancer cell line,,,,,,,NCI-H266,PMID:40025578,10.1186/s40478-025-01965-6,Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment.,,"NCI-H266 (a lung carcinoma cell line, used as target cells)",0.8,Accept,Experimental Usage
RES015a8eda,Neurofibromatosis 1 fibroblasts,Skin,Dermal,,Neurofibromatosis Type 1,Finite cell line,,,,,,,Neurofibromatosis 1 fibroblasts,PMID:34011935,10.1038/s41419-021-03802-9,Metalloproteinase 1 downregulation in neurofibromatosis 1: Therapeutic potential of antimalarial hydroxychloroquine and chloroquine.,,applied treatments...in cultured Neurofibromatosis 1 fibroblasts,0.85,Accept,Experimental Usage
RESf6ce18b7,MPNST-SP-01,Nerve,Peripheral nerve sheath,Malignant Peripheral Nerve Sheath Tumor,,Cancer cell line,,,,,,,MPNST-SP-01,PMID:35511749,10.1158/1535-7163.MCT-21-0947,A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.,,"The establishment of the MPNST-SP-01, MPNST-NF1-08, and MPNST-NF1-9 cell lines at the Catalan Institute of Oncology is described...",0.9,Accept,Experimental Usage
RESebfbb29f,MPNST-NF1-08,Nerve,Peripheral nerve sheath,Malignant Peripheral Nerve Sheath Tumor,Neurofibromatosis Type 1,Cancer cell line,,,,,,,MPNST-NF1-08,PMID:35511749,10.1158/1535-7163.MCT-21-0947,A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.,,"The establishment of the MPNST-SP-01, MPNST-NF1-08, and MPNST-NF1-9 cell lines at the Catalan Institute of Oncology is described...",0.9,Accept,Experimental Usage
RES62b59d33,MPNST-NF1-9,Nerve,Peripheral nerve sheath,Malignant Peripheral Nerve Sheath Tumor,Neurofibromatosis Type 1,Cancer cell line,,,,,,,MPNST-NF1-9,PMID:35511749,10.1158/1535-7163.MCT-21-0947,A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.,,"The establishment of the MPNST-SP-01, MPNST-NF1-08, and MPNST-NF1-9 cell lines at the Catalan Institute of Oncology is described...",0.9,Accept,Experimental Usage
RESb82893e4,HS-PSS,Nerve,Peripheral nerve sheath,Malignant Peripheral Nerve Sheath Tumor,,Cancer cell line,,,,,,,HS-PSS,PMID:35511749,10.1158/1535-7163.MCT-21-0947,A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.,,"STS-26T (19), HS-PSS, HS-sch2 (20), S462 (21), and sNF96.2 (22) cell lines were previously established in other laboratories.",0.85,Accept,Experimental Usage
RES871bb6fa,HS-Sch-2,Nerve,Peripheral nerve sheath,Malignant Peripheral Nerve Sheath Tumor,,Cancer cell line,,,,,,,HS-Sch-2,PMID:32642733 | PMID:35511749,10.1093/noajnl/vdz061 | 10.1158/1535-7163.MCT-21-0947,KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors. | A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.,,"sporadic HS-Sch-2 (obtained from RIKEN) | STS-26T (19), HS-PSS, HS-sch2 (20), S462 (21), and sNF96.2 (22) cell lines were previously established in other laboratories.",0.9,Accept,Experimental Usage
RES94d99650,Human Foreskin Fibroblast (HFF),Skin,Foreskin,,,Finite cell line,,,,,,,Human Foreskin Fibroblast (HFF),PMID:35511749,10.1158/1535-7163.MCT-21-0947,A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.,,The Human Foreskin Fibroblast (HFF) cell line was purchased from ATCC (American Type Culture Collection).,0.8,Accept,Experimental Usage
RESdf9174e6,ipNF95.11b C-RFP,Nerve,Plexiform neurofibroma,Plexiform Neurofibroma,Neurofibromatosis Type 1,Cancer cell line,,,,,,,ipNF95.11b C-RFP,PMID:39061138,10.3390/cancers16142498,A Fibroblast-Derived Secretome Stimulates the Growth and Invasiveness of 3D Plexiform Neurofibroma Spheroids.,,"ipNF95.11b C gifted from Dr. Margaret Wallace (University of Florida, USA) was lentivirally transduced with red fluorescent protein (RFP)",0.9,Accept,Experimental Usage
RESca37f0db,AC007-hTERT,Brain,Arachnoid,,Neurofibromatosis Type 2,Finite cell line,,,,,,,AC007-hTERT,PMID:26219339,10.18632/oncotarget.4858,A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas.,,immortalized arachnoid AC007-hTERT derived from an NF2 patient expressing heterozygous level of NF2,0.9,Accept,Experimental Usage
RESeae42705,AC028,Brain,Arachnoid,,,Finite cell line,,,,,,,AC028,PMID:26219339,10.18632/oncotarget.4858,A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas.,,primary normal arachnoid AC028,0.85,Accept,Experimental Usage
RES02cd4945,U87-MG,Brain,Central nervous system,Glioblastoma,Neurofibromatosis Type 1,Cancer cell line,,,,,,,U87-MG,PMID:28166733,10.1186/s12864-017-3519-7,A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma.,,U87-MG and HEK293T cells were purchased from ATCC. Cell lines were regularly passaged and were cultured in Dulbecco's Modified Eagle Medium,0.95,Accept,Experimental Usage
RES7ec195a8,Meso-33,Lung,,Mesothelioma,Neurofibromatosis Type 2,Cancer cell line,,,,,,,Meso-33,PMID:25026211,10.1016/j.ccr.2014.05.001,Merlin/NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the hippo pathway kinases Lats1 and 2 in the nucleus.,,plated in 0.34% low melting temperature agarose (FMC Bioproducts) in complete medium at 2×10 4 (Meso-33 cells),0.9,Accept,Experimental Usage
RESba34146c,FC-1801,Nerve,,,Neurofibromatosis Type 2,Cancer cell line,,,,,,,FC-1801,PMID:25026211,10.1016/j.ccr.2014.05.001,Merlin/NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the hippo pathway kinases Lats1 and 2 in the nucleus.,,"1.2×10 4 (FC-1801 cells) per well in 24-well Ultra Low Cluster Plates (Costar). For tumorigenicity assay, 1×10 6 FC-1801 cells were suspended",0.9,Accept,Experimental Usage
RES331e6cdf,NIH-3T3,Embryonic tissue,,,,Finite cell line,,,,,,,NIH-3T3,PMID:21072183,10.1371/journal.pone.0013791,p21-Activated kinases are required for transformation in a cell-based model of neurofibromatosis type 2.,,NIH-3T3 (obtained from American Type Culture Collection) cells were cultured in high-glucose DMEM,0.9,Accept,Experimental Usage
RES27693bb3,φNX packaging cell line,Kidney,,,,Finite cell line,,,,,,,φNX packaging,PMID:21072183,10.1371/journal.pone.0013791,p21-Activated kinases are required for transformation in a cell-based model of neurofibromatosis type 2.,,The φNX packaging cell line (Orbigen) was transfected using Lipofectamine 2000,0.85,Accept,Experimental Usage
RESc7b181eb,H1838,Nerve,Peripheral nerve sheath,Malignant Peripheral Nerve Sheath Tumor,Neurofibromatosis Type 1,Cancer cell line,,,,,,,H1838,PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,"H1838 was obtained from the American Type Culture Collection (ATCC, Manassas, VA)",0.85,Accept,Experimental Usage
RES2a6648a2,WM3918,Nerve,Peripheral nerve sheath,Malignant Peripheral Nerve Sheath Tumor,Neurofibromatosis Type 1,Cancer cell line,,,,,,,WM3918,PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,WM3918 and M308 were obtained from Dr. David Solit at Memorial Sloan Kettering Cancer Center,0.85,Accept,Experimental Usage
RESa889216f,M308,Nerve,Peripheral nerve sheath,Malignant Peripheral Nerve Sheath Tumor,Neurofibromatosis Type 1,Cancer cell line,,,,,,,M308,PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,WM3918 and M308 were obtained from Dr. David Solit at Memorial Sloan Kettering Cancer Center,0.85,Accept,Experimental Usage
RES7d84433c,NF90-8,Nerve,Peripheral nerve sheath,Malignant Peripheral Nerve Sheath Tumor,Neurofibromatosis Type 1,Cancer cell line,,,,,,,NF90-8,PMID:18367665 | PMID:33658640 | PMID:33032988,10.1124/jpet.107.135830 | 10.1038/s41416-021-01270-8 | 10.1158/0008-5472.CAN-20-1365,Induction of apoptosis in neurofibromatosis type 1 malignant peripheral nerve sheath tumor cell lines by a combination of novel farnesyl transferase inhibitors and lovastatin. | Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours. | Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,"NF90-8 and ST88-14 MPNST cell lines were generously donated by T. Glover (University of Michigan, Ann Arbor, MI) | malignant peripheral nerve sheath tumour (MPNST) cell lines ST88-14, S462 and NF90-8 | STS26T, ST8814 and NF90.8 were kindly provided by Dr. Gregory Riggins at Johns Hopkins University",0.95,Accept,Experimental Usage
RES8cd5f20e,NF10.1,Nerve,Peripheral nerve sheath,Malignant Peripheral Nerve Sheath Tumor,Neurofibromatosis Type 1,Cancer cell line,,,,,,,NF10.1,PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,"NF94.3, NF96.2, NF10.1 and NF11.1 were kindly provided by Dr. Margaret Wallace at University of Florida",0.85,Accept,Experimental Usage
RES437abbbb,NF11.1,Nerve,Peripheral nerve sheath,Malignant Peripheral Nerve Sheath Tumor,Neurofibromatosis Type 1,Cancer cell line,,,,,,,NF11.1,PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,"NF94.3, NF96.2, NF10.1 and NF11.1 were kindly provided by Dr. Margaret Wallace at University of Florida",0.85,Accept,Experimental Usage
RESdb3ab40e,K4622 grade II glioma cell line,Brain,Brain,Grade II glioma,Neurofibromatosis Type 1,Cancer cell line,,,,,,,K4622 grade II glioma,PMID:21216928,10.1158/1535-7163.MCT-10-0654,Interpreting mammalian target of rapamycin and cell growth inhibition in a genetically engineered mouse model of Nf1-deficient astrocytes.,,The mouse K4622 grade II glioma cell line was derived from a C57Bl/6 Nf1+/−; p53+/− mouse and was shown to be both Nf1- and p53-deficient,0.9,Accept,Experimental Usage
RES0e69a08f,HSR-GBM1,Brain,Glioblastoma,Glioblastoma,Neurofibromatosis Type 1,Cancer cell line,,,,,,,HSR-GBM1,PMID:38714355,10.1158/1535-7163.MCT-23-0510,MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma.,,"Human-derived glioblastoma neurosphere lines (HSR-GBM1, JHH-520, JHU-0879, JHU-1016B, JHH-136) with diverse NF1 status were obtained and cultured",0.9,Accept,Experimental Usage
RES7d16532b,JHH-520 cell line,Brain,Glioblastoma,Glioblastoma,,Cancer cell line,,,,,,,JHH-520,PMID:39472976 | PMID:38714355,10.1186/s40478-024-01875-z | 10.1158/1535-7163.MCT-23-0510,NF1 expression profiling in IDH-wildtype glioblastoma: genomic associations and survival outcomes. | MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma.,,"glioblastoma neurosphere lines with previously characterized levels of NF1 expression: JHH-520 (NF1-deficient) | Human-derived glioblastoma neurosphere lines (HSR-GBM1, JHH-520, JHU-0879, JHU-1016B, JHH-136) with diverse NF1 status were obtained and cultured",0.95,Accept,Experimental Usage
RES7cfe241c,JHU-0879,Brain,Glioblastoma,Glioblastoma,Neurofibromatosis Type 1,Cancer cell line,,,,,,,JHU-0879,PMID:38714355,10.1158/1535-7163.MCT-23-0510,MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma.,,"Human-derived glioblastoma neurosphere lines (HSR-GBM1, JHH-520, JHU-0879, JHU-1016B, JHH-136) with diverse NF1 status were obtained and cultured",0.9,Accept,Experimental Usage
RESd39ec166,JHU-1016B,Brain,Glioblastoma,Glioblastoma,Neurofibromatosis Type 1,Cancer cell line,,,,,,,JHU-1016B,PMID:38714355,10.1158/1535-7163.MCT-23-0510,MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma.,,"Human-derived glioblastoma neurosphere lines (HSR-GBM1, JHH-520, JHU-0879, JHU-1016B, JHH-136) with diverse NF1 status were obtained and cultured",0.9,Accept,Experimental Usage
RESe586e098,JHH-136,Brain,Glioblastoma,Glioblastoma,Neurofibromatosis Type 1,Cancer cell line,,,,,,,JHH-136,PMID:38714355,10.1158/1535-7163.MCT-23-0510,MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma.,,"Human-derived glioblastoma neurosphere lines (HSR-GBM1, JHH-520, JHU-0879, JHU-1016B, JHH-136) with diverse NF1 status were obtained and cultured",0.9,Accept,Experimental Usage
RES7ba5993a,B76,Brain,High-grade glioma,High-grade glioma,Neurofibromatosis Type 1,Cancer cell line,,,,,,,B76,PMID:38714355,10.1158/1535-7163.MCT-23-0510,MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma.,,"Adherent high-grade glioma lines with BRAF V600E alteration and varied NF1 status (B76, NGT-41, NMCG-1, DBTRG) were obtained",0.85,Accept,Experimental Usage
RES8d501cc9,NGT-41,Brain,High-grade glioma,High-grade glioma,Neurofibromatosis Type 1,Cancer cell line,,,,,,,NGT-41,PMID:38714355,10.1158/1535-7163.MCT-23-0510,MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma.,,"Adherent high-grade glioma lines with BRAF V600E alteration and varied NF1 status (B76, NGT-41, NMCG-1, DBTRG) were obtained",0.85,Accept,Experimental Usage
RES240e5436,NMCG-1,Brain,High-grade glioma,High-grade glioma,Neurofibromatosis Type 1,Cancer cell line,,,,,,,NMCG-1,PMID:38714355,10.1158/1535-7163.MCT-23-0510,MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma.,,"Adherent high-grade glioma lines with BRAF V600E alteration and varied NF1 status (B76, NGT-41, NMCG-1, DBTRG) were obtained",0.85,Accept,Experimental Usage
RES25623437,DBTRG,Brain,High-grade glioma,High-grade glioma,Neurofibromatosis Type 1,Cancer cell line,,,,,,,DBTRG,PMID:38714355,10.1158/1535-7163.MCT-23-0510,MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma.,,"Adherent high-grade glioma lines with BRAF V600E alteration and varied NF1 status (B76, NGT-41, NMCG-1, DBTRG) were obtained",0.85,Accept,Experimental Usage
RESd8d494a3,T98G,Brain,Glioblastoma,Glioblastoma,,Cancer cell line,,,,,,,T98G,PMID:38714355,10.1158/1535-7163.MCT-23-0510,MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma.,,"LN229 was obtained from ATCC, T98G was a gift from the Laterra laboratory, and both were cultured as recommended",0.8,Accept,Experimental Usage
RES874fed52,U251,Brain,Glioma,Glioma,,Cancer cell line,,,,,,,U251,PMID:32419643 | PMID:33934112 | PMID:25043298,10.1177/1533033820919759 | 10.1038/s41419-021-03716-6 | 10.1038/onc.2014.185,Long Noncoding RNA WT1-AS Inhibit Cell Malignancy via miR-494-3p in Glioma. | HIF1α-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxia. | Oncogenic role of Merlin/NF2 in glioblastoma.,,"4 glioma cell lines (U87, U118, U251, and A172) were commercially procured from Shanghai Cell Bank of the Chinese Academy of Sciences | Experiments were performed on human U87 and U251 glioblastoma cells | By selecting sub-populations of U251 glioblastoma cells, we observed that high expression of phosphorylated Merlin...",0.9,Accept,Experimental Usage
RES828ab613,PNF-derived Schwann cells,Nerve,Peripheral nerve sheath,Plexiform Neurofibroma,Neurofibromatosis Type 1,Finite cell line,,,,,,,PNF-derived Schwann,PMID:25340526,10.1371/journal.pone.0107760,Nilotinib is more potent than imatinib for treating plexiform neurofibroma in vitro and in vivo.,,"Schwann cells from the PNF were cultured and identified as previously described. After ensuring purity of 85%, PNF-derived Schwann cells were treated with nilotinib and imatinib",0.85,Accept,Experimental Usage
RES9927ef7e,GBM1 cell line,Brain,Glioblastoma,Glioblastoma,,Cancer cell line,,,,,,,GBM1,PMID:39472976,10.1186/s40478-024-01875-z,NF1 expression profiling in IDH-wildtype glioblastoma: genomic associations and survival outcomes.,,"glioblastoma neurosphere lines with previously characterized levels of NF1 expression: JHH-520 (NF1-deficient), GBM1 (NF1-intact)",0.9,Accept,Experimental Usage
RESbd60dbd9,JHH-0879 cell line,Brain,Glioblastoma,Glioblastoma,,Cancer cell line,,,,,,,JHH-0879,PMID:39472976,10.1186/s40478-024-01875-z,NF1 expression profiling in IDH-wildtype glioblastoma: genomic associations and survival outcomes.,,"glioblastoma neurosphere lines with previously characterized levels of NF1 expression: JHH-520 (NF1-deficient), GBM1 (NF1-intact), and JHH-0879 (NF1-intact)",0.9,Accept,Experimental Usage
RESeba89533,S520,Nerve,Peripheral nerve sheath,Malignant Peripheral Nerve Sheath Tumor,Neurofibromatosis Type 1,Cancer cell line,,,,,,,S520,PMID:20049725 | PMID:18483311,10.1002/emmm.200900027 | 10.1158/1535-7163.MCT-07-2335,Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene. | Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors.,,"We maintained MPNST cell lines ST88-14, STS26T, S520, S462, 88-3, 90-8 and YST1 | MPNST cell lines STS26T, ST8814, ST88-3 S462, T265p21, S520, 90–8, and YST1...All cell lines were from NF1 patients except YST-1 and STS26T",0.9,Accept,Experimental Usage
RES82831da4,88-3,Nerve,Peripheral nerve sheath,Malignant Peripheral Nerve Sheath Tumor,Neurofibromatosis Type 1,Cancer cell line,,,,,,,88-3,PMID:20049725,10.1002/emmm.200900027,Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene.,,"We maintained MPNST cell lines ST88-14, STS26T, S520, S462, 88-3, 90-8 and YST1",0.9,Accept,Experimental Usage
RESc41540f6,YST1,Nerve,Peripheral nerve sheath,Malignant Peripheral Nerve Sheath Tumor,Neurofibromatosis Type 1,Cancer cell line,,,,,,,YST1,PMID:20049725 | PMID:18483311,10.1002/emmm.200900027 | 10.1158/1535-7163.MCT-07-2335,Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene. | Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors.,,"We maintained MPNST cell lines ST88-14, STS26T, S520, S462, 88-3, 90-8 and YST1 | MPNST cell lines STS26T, ST8814, ST88-3 S462, T265p21, S520, 90–8, and YST1...All cell lines were from NF1 patients except YST-1 and STS26T",0.9,Accept,Experimental Usage
RES1f1514dd,icNF98.4c,Nerve,Cutaneous neurofibroma,Cutaneous neurofibroma,Neurofibromatosis Type 1,Finite cell line,,,,,,,icNF98.4c,PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,immortalized cNF cell lines through transduction with wild-type human telomerase reverse transcriptase (hTERT) and murine cyclin-dependent kinase 4 (mCdk4) genes,0.95,Accept,Development
RES42459202,icNF00.10a,Nerve,Cutaneous neurofibroma,Cutaneous neurofibroma,Neurofibromatosis Type 1,Finite cell line,,,,,,,icNF00.10a,PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,immortalized cNF cell lines through transduction with wild-type human telomerase reverse transcriptase (hTERT) and murine cyclin-dependent kinase 4 (mCdk4) genes,0.95,Accept,Development
RES458b9b4f,icNF04.9a,Nerve,Cutaneous neurofibroma,Cutaneous neurofibroma,Neurofibromatosis Type 1,Finite cell line,,,,,,,icNF04.9a,PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,immortalized cNF cell lines through transduction with wild-type human telomerase reverse transcriptase (hTERT) and murine cyclin-dependent kinase 4 (mCdk4) genes,0.95,Accept,Development
RES0be2e415,i28cNF,Nerve,Cutaneous neurofibroma,Cutaneous neurofibroma,Neurofibromatosis Type 1,Finite cell line,,,,,,,i28cNF,PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,immortalized cNF cell lines through transduction with wild-type human telomerase reverse transcriptase (hTERT) and murine cyclin-dependent kinase 4 (mCdk4) genes,0.95,Accept,Development
RESa3568ca9,i18cNF,Nerve,Cutaneous neurofibroma,Cutaneous neurofibroma,Neurofibromatosis Type 1,Finite cell line,,,,,,,i18cNF,PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,immortalized cNF cell lines through transduction with wild-type human telomerase reverse transcriptase (hTERT) and murine cyclin-dependent kinase 4 (mCdk4) genes,0.95,Accept,Development
RESbcad377e,i21cNF,Nerve,Cutaneous neurofibroma,Cutaneous neurofibroma,Neurofibromatosis Type 1,Finite cell line,,,,,,,i21cNF,PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,immortalized cNF cell lines through transduction with wild-type human telomerase reverse transcriptase (hTERT) and murine cyclin-dependent kinase 4 (mCdk4) genes,0.95,Accept,Development
RES1aa9a303,CCD-1112Sk,Skin,Foreskin,,,Finite cell line,,,,,,,CCD-1112Sk,PMID:32642733,10.1093/noajnl/vdz061,KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors.,,the commercial human foreskin fibroblast (HFF) cell line CCD-1112Sk (ATCC),0.9,Accept,Experimental Usage
RES40c42020,Rosetta2(DE3) competent cells,Bacteria,,,,Finite cell line,,,,,,,Rosetta2(DE3) competent,PMID:24882693,10.1016/j.jmb.2014.05.011,Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study.,,"The expression plasmids were transformed into the Rosetta2(DE3) competent cells (EMD Biosciences, Inc)",0.85,Accept,Experimental Usage
RES8fd7beb2,ST88-3,Nerve,Peripheral nerve sheath,Malignant Peripheral Nerve Sheath Tumor,Neurofibromatosis Type 1,Cancer cell line,,,,,,,ST88-3,PMID:18483311,10.1158/1535-7163.MCT-07-2335,Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors.,,"MPNST cell lines STS26T, ST8814, ST88-3 S462, T265p21, S520, 90–8, and YST1...All cell lines were from NF1 patients except YST-1 and STS26T",0.9,Accept,Experimental Usage
REScea4eddb,T265p21,Nerve,Peripheral nerve sheath,Malignant Peripheral Nerve Sheath Tumor,Neurofibromatosis Type 1,Cancer cell line,,,,,,,T265p21,PMID:18483311,10.1158/1535-7163.MCT-07-2335,Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors.,,"MPNST cell lines STS26T, ST8814, ST88-3 S462, T265p21, S520, 90–8, and YST1...All cell lines were from NF1 patients except YST-1 and STS26T",0.9,Accept,Experimental Usage
RESe2bfa3a9,DS-red STS26T cell line,Nerve,Peripheral nerve sheath,Malignant Peripheral Nerve Sheath Tumor,,Cancer cell line,,,,,,,DS-red STS26T,PMID:18483311,10.1158/1535-7163.MCT-07-2335,Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors.,,Mice were injected s.c. with a stably transfected DS-red STS26T cell line,0.9,Accept,Experimental Usage
RES487eca0a,hTERT ipNF05.5,Nerve,Peripheral nerve sheath,Plexiform neurofibroma,Neurofibromatosis Type 1,Cancer cell line,,,,,,,hTERT ipNF05.5,PMID:37140985,10.1172/JCI168227,Basement membrane proteins in extracellular matrix characterize NF1 neurofibroma development and response to MEK inhibitor.,,"The human pNF cell line hTERT ipNF05.5 (ATCC, CRL-3388) and the normal Schwann cell line hTERT ipn02.3 2λ (ATCC, CRL-3392)...",0.95,Accept,Experimental Usage
RESe9e677f7,hTERT ipn02.3 2λ,Nerve,Peripheral nerve sheath,,,Finite cell line,,,,,,,hTERT ipn02.3 2λ,PMID:37140985 | PMID:38127282,10.1172/JCI168227 | 10.1158/1078-0432.CCR-23-2548,Basement membrane proteins in extracellular matrix characterize NF1 neurofibroma development and response to MEK inhibitor. | Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,"...and the normal Schwann cell line hTERT ipn02.3 2λ (ATCC, CRL-3392) were cultured in DMEM... | Immortalized human normal (hTERT ipn02.3 2λ) and NF1 deficient neurofibroma Schwann cells",0.9,Accept,Experimental Usage
RES8e44a7c5,E13.5 DRG neurosphere cells,Nerve,Dorsal root ganglion,,Neurofibromatosis Type 1,Finite cell line,,,,,,,E13.5 DRG neurosphere,PMID:37140985,10.1172/JCI168227,Basement membrane proteins in extracellular matrix characterize NF1 neurofibroma development and response to MEK inhibitor.,,"Isolation and culture of E13.5 DRG neurosphere cells were performed as previously described (6, 9, 52).",0.8,Accept,Experimental Usage
RES70f6328b,Daoy,Brain,Cerebellum,Medulloblastoma,,Cancer cell line,,,,,,,Daoy,PMID:20551058,10.1158/0008-5472.CAN-09-3769,Cyclic AMP suppression is sufficient to induce gliomagenesis in a mouse model of neurofibromatosis-1.,,expression and activity of catalytically active and inactive PDE4A1 constructs were determined first in Daoy medulloblastoma cells (American Type Culture Collection),0.85,Accept,Experimental Usage
RESc5815f89,NF1-/- iPSC-derived neural crest cells,Nerve,Neural crest,,Neurofibromatosis Type 1,Embryonic stem cell,,,,,,,NF1-/- iPSC-derived neural crest,PMID:38175707,10.1172/jci.insight.168826,Unbalancing cAMP and Ras/MAPK pathways as a therapeutic strategy for cutaneous neurofibromas.,,NF1–/– iPSC-derived neural crest cells were plated in SC differentiation media for 5 days,0.85,Accept,Experimental Usage
RES05f18fad,hTERT NF1 ipNF95.6 cell line,Nerve,Peripheral nerve,Neurofibroma,Neurofibromatosis Type 1,Finite cell line,,,,,,,hTERT NF1 ipNF95.6,PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,NF1 deficient neurofibroma Schwann cells (hTERT NF1 ipNF95.6) were obtained from Dr. Peggy Wallace,0.85,Accept,Experimental Usage
RES4619f98d,ipNF05.5-MX,Nerve,Peripheral nerve sheath,Plexiform Neurofibroma,Neurofibromatosis Type 1,Cancer cell line,,,,,,,ipNF05.5-MX,PMID:38136356,10.3390/cancers15245811,Drug Responses in Plexiform Neurofibroma Type I (PNF1) Cell Lines Using High-Throughput Data and Combined Effectiveness and Potency.,,"...NF1 −/− plexiform neurofibroma cell lines (PNF1 cells) ipNF05.5-MX, ipNF06.2A, ipNF95.11b C/T, and ipNF95.6 as test lines...",0.9,Accept,Experimental Usage
RES5d59f7d9,ipNF95.11b C/T,Nerve,Peripheral nerve sheath,Plexiform Neurofibroma,Neurofibromatosis Type 1,Cancer cell line,,,,,,,ipNF95.11b C/T,PMID:38136356,10.3390/cancers15245811,Drug Responses in Plexiform Neurofibroma Type I (PNF1) Cell Lines Using High-Throughput Data and Combined Effectiveness and Potency.,,"...NF1 −/− plexiform neurofibroma cell lines (PNF1 cells) ipNF05.5-MX, ipNF06.2A, ipNF95.11b C/T, and ipNF95.6 as test lines...",0.9,Accept,Experimental Usage
RES0fc58348,ipNF02.3 2λ,Nerve,Peripheral nerve,,,Finite cell line,,,,,,,ipNF02.3 2λ,PMID:38136356,10.3390/cancers15245811,Drug Responses in Plexiform Neurofibroma Type I (PNF1) Cell Lines Using High-Throughput Data and Combined Effectiveness and Potency.,,"...additional neurofibromin-competent cell lines, specifically human foreskin fibroblasts [HFF] and the Schwann cell lines ipNF02.3 2λ, ipNF02.8...",0.85,Accept,Experimental Usage
RES9e84f002,ipNF02.8,Nerve,Peripheral nerve,,,Finite cell line,,,,,,,ipNF02.8,PMID:38136356,10.3390/cancers15245811,Drug Responses in Plexiform Neurofibroma Type I (PNF1) Cell Lines Using High-Throughput Data and Combined Effectiveness and Potency.,,"...additional neurofibromin-competent cell lines, specifically human foreskin fibroblasts [HFF] and the Schwann cell lines ipNF02.3 2λ, ipNF02.8...",0.85,Accept,Experimental Usage
RESf59f8ed8,NF95.11b,Nerve,Peripheral nerve sheath,Neurofibroma,Neurofibromatosis Type 1,Cancer cell line,,,,,,,NF95.11b,PMID:38216572,10.1038/s41467-024-44755-9,Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance.,,"Patient-derived neurofibroma (NF95.11b, NF95.6) or MPNST (SNF02.2, SNF94.3, SNF96.2, ST88-14) cell lines",0.9,Accept,Experimental Usage
RES250e44b5,NF95.6,Nerve,Peripheral nerve sheath,Neurofibroma,Neurofibromatosis Type 1,Cancer cell line,,,,,,,NF95.6,PMID:38216572,10.1038/s41467-024-44755-9,Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance.,,"Patient-derived neurofibroma (NF95.11b, NF95.6) or MPNST (SNF02.2, SNF94.3, SNF96.2, ST88-14) cell lines",0.9,Accept,Experimental Usage
RES920f4fcf,SNF94.3,Nerve,Peripheral nerve sheath,Malignant Peripheral Nerve Sheath Tumor,Neurofibromatosis Type 1,Cancer cell line,,,,,,,SNF94.3,PMID:38216572,10.1038/s41467-024-44755-9,Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance.,,"Patient-derived neurofibroma (NF95.11b, NF95.6) or MPNST (SNF02.2, SNF94.3, SNF96.2, ST88-14) cell lines",0.9,Accept,Experimental Usage
RES9723ccfe,JW18.2,Nerve,Peripheral nerve sheath,Malignant Peripheral Nerve Sheath Tumor,Neurofibromatosis Type 1,Cancer cell line,,,,,,,JW18.2,PMID:38216572,10.1038/s41467-024-44755-9,Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance.,,Subcutaneous allografts were performed by implanting 5 million JW18.2 or JW23.3 MPNST allografts cells,0.85,Accept,Experimental Usage
RES80dcb249,JW23.3,Nerve,Peripheral nerve sheath,Malignant Peripheral Nerve Sheath Tumor,Neurofibromatosis Type 1,Cancer cell line,,,,,,,JW23.3,PMID:38216572,10.1038/s41467-024-44755-9,Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance.,,Subcutaneous allografts were performed by implanting 5 million JW18.2 or JW23.3 MPNST allografts cells,0.85,Accept,Experimental Usage
RESb1b27a6d,KT21-MG1,Brain,Meninges,Meningioma,Neurofibromatosis Type 2,Cancer cell line,,,,,,,KT21-MG1,PMID:36148553,10.1093/brain/awac342,Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma.,,meningioma cell lines BenMen-1 (Grade 1) and KT21-MG1 (Grade 3) were cultured in DMEM/10% FBS,0.9,Accept,Experimental Usage
RESd536c7d1,293FT,Kidney,,,,Cancer cell line,,,,,,,293FT,PMID:36148553,10.1093/brain/awac342,Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma.,,Viral media was produced using 293FT cells transfected using Fugene 6 (Promega) in optiMEM (Gibco),0.85,Accept,Experimental Usage
RES33a9f0e9,NF2 primary fibroblasts,Skin,Connective tissue,,Neurofibromatosis Type 2,Finite cell line,,,,,,,NF2 primary fibroblasts,PMID:36420221,10.1016/j.omtn.2022.10.026,Antisense oligonucleotides targeting exon 11 are able to partially rescue the NF2-related schwannomatosis phenotype ,,Patient primary fibroblasts carrying NF2 germline pathogenic variants were treated with the specific single or paired PMOs,0.9,Accept,Experimental Usage
RESf476bcb6,Primary human vestibular schwannoma (VS) cell cultures,Nerve,Vestibular nerve,Vestibular Schwannoma,Neurofibromatosis Type 2,Finite cell line,,,,,,,Primary human vestibular schwannoma (VS) cell cultures,PMID:32438526,10.1002/lary.28671,Effects of Neurod1 Expression on Mouse and Human Schwannoma Cells.,,Primary human vestibular schwannoma (VS) cell cultures were transduced with adenoviral vectors expressing Neurod1,0.9,Accept,Experimental Usage
RES4140cd3d,Primary normal rat Schwann cells,Nerve,Sciatic nerve,,,Finite cell line,,,,,,,Primary normal rat Schwann,PMID:18367665,10.1124/jpet.107.135830,Induction of apoptosis in neurofibromatosis type 1 malignant peripheral nerve sheath tumor cell lines by a combination of novel farnesyl transferase inhibitors and lovastatin.,,Primary normal rat Schwann cells were isolated from the sciatic nerves of neonatal Sprague-Davey Rats,0.85,Accept,Experimental Usage
RES21be72dc,ipNF05.5 Mixed Clones,Nerve,Peripheral nerve,Plexiform Neurofibroma,Neurofibromatosis Type 1,Cancer cell line,,,,,,,ipNF05.5 Mixed Clones,PMID:40723243,10.3390/cancers17142359,The Combination of HSP90 Inhibitors and Selumetinib Reinforces the Inhibitory Effects on Plexiform Neurofibromas.,,"pNF cell lines, ipNF95.11bC, ipnNF95.11c, ipNF05.5 Single Clone, and ipNF05.5 Mixed Clones were obtained from the American Type Culture Collection",0.9,Accept,Experimental Usage
RES3e51adf0,Nf1flox/flox bone marrow stromal cells,Bone,Bone marrow,,Neurofibromatosis Type 1,,,,,,,,Nf1flox/flox bone marrow stromal,PMID:25043591,10.1002/jbmr.2316,Combined MEK inhibition and BMP2 treatment promotes osteoblast differentiation and bone healing in Nf1Osx -/- mice.,,ex vivo-based cell culture approach based on the use of Nf1(flox/flox) bone marrow stromal cells,0.8,Accept,Experimental Usage
RES036a0bbd,DH5α bacteria,Bacterial,,,,Finite cell line,,,,,,,DH5α bacteria,PMID:19144871,10.3181/0809-RM-275,Identification of erythrocyte p55/MPP1 as a binding partner of NF2 tumor suppressor protein/Merlin.,,"The fusion proteins, MBP-merlin-N and MBP-merlin-C, were expressed in the DH5α bacteria and purified using the amylose resin",0.8,Accept,Experimental Usage
RES642f055b,tail-tip fibroblasts (TTFs),Skin,Tail-tip fibroblasts,,,Finite cell line,,,,,,,tail-tip fibroblasts (TTFs),PMID:28392281,10.1016/j.expneurol.2017.04.001,Human stem cell modeling in neurofibromatosis type 1 (NF1).,,The first direct lineage conversion of post-mitotic neurons from mouse embryonic fibroblasts (MEFs) and tail-tip fibroblasts (TTFs),0.9,Accept,Experimental Usage
RES7b2e113f,Neural stem cells,Brain,fetal brain,,,Finite cell line,,,,,,,Neural stem,PMID:36241865,10.1038/s12276-022-00850-9,Transplanting neurofibromatosis-1 gene knockout neural stem cells improve functional recovery in rats with spinal cord injury by enhancing the mTORC2 pathway.,,NSCs were obtained from the fetal brains of embryonic Day 14 pregnant Sprague‒Dawley rats,0.8,Accept,Experimental Usage
RES07add6ac,Nf2-deficient spinal cord neural progenitor cells,Nerve,Spinal cord,,Neurofibromatosis Type 2,Finite cell line,,,,,,,Nf2-deficient spinal cord neural progenitor,PMID:24817309,10.1371/journal.pone.0097320,Nf2/Merlin controls spinal cord neural progenitor function in a Rac1/ErbB2-dependent manner.,,we leveraged primary mouse Nf2-deficient spinal cord neural progenitor cells,0.9,Accept,Experimental Usage
RESce5c25bd,NSF1,Nerve,Peripheral nerve sheath,Malignant Peripheral Nerve Sheath Tumor,Neurofibromatosis Type 1,Cancer cell line,,,,,,,NSF1,PMID:41001593 | PMID:32948135,10.1080/23723556.2025.2561292 | 10.1186/s12885-020-07397-w,Loss of Schwann cell's normal rhythmic core clock gene expression and gain of rhythmic expression of oncogenic driver genes in malignant NF1-associated peripheral nerve sheath tumor. | Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model.,,"Human T265, S462, and NSF1 cell lines of malignant peripheral nerve sheath tumors (MPNSTs) being associated with neurofibromatosis type 1 | NSF1 cells were kindly provided by Dieter Kaufmann (University Hospital Ulm, Germany)",0.9,Accept,Experimental Usage
RES93a28363,BRGN,Unknown,,,,Finite cell line,,,,,,,BRGN,PMID:41001593,10.1080/23723556.2025.2561292,Loss of Schwann cell's normal rhythmic core clock gene expression and gain of rhythmic expression of oncogenic driver genes in malignant NF1-associated peripheral nerve sheath tumor.,,BRGN control cells used in this study were previously described,0.8,Accept,Experimental Usage
RESe7efd56d,primary human Schwann cells (HSC),Nerve,Peripheral nerve,,,Finite cell line,,,,,,,primary human Schwann cells (HSC),PMID:41001593,10.1080/23723556.2025.2561292,Loss of Schwann cell's normal rhythmic core clock gene expression and gain of rhythmic expression of oncogenic driver genes in malignant NF1-associated peripheral nerve sheath tumor.,,"The primary human Schwann cells (HSC) were obtained by ScienCell (#1700, Carlsbad, CA, USA)",0.85,Accept,Experimental Usage
RES6382be4a,Normal human Schwann cells (HSC),Nerve,Peripheral nerve,,,Finite cell line,,,,,,,Normal human Schwann cells (HSC),PMID:38203448,10.3390/ijms25010277,FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells.,,"Normal human Schwann cells (HSC) (ScienCell Research Laboratories, Carlsbad, CA, USA) were grown on the poly-L-lysine-coated tissue culture plates",0.85,Accept,Experimental Usage
RESb987fd97,B8 fibroblasts,Connective tissue,,,,Finite cell line,,,,,,,B8 fibroblasts,PMID:32948135,10.1186/s12885-020-07397-w,Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model.,,"Mouse fibroblast B8 cells (kindly provided by Ralf Stohwasser, Brandenburg Technical University Cottbus-Senftenberg)",0.85,Accept,Experimental Usage
RESea197438,95.6,Nerve,Schwann cells,,Neurofibromatosis Type 1,Finite cell line,,,,,,,95.6,PMID:33658640,10.1038/s41416-021-01270-8,Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours.,,Immortalised human Schwann cell lines with mutant NF1 (ipNF05.5 and 95.6) and wt NF1 (ipn02.3),0.9,Accept,Experimental Usage
RESfd5f7e36,ipn02.3,Nerve,Schwann cells,,,Finite cell line,,,,,,,ipn02.3,PMID:33658640,10.1038/s41416-021-01270-8,Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours.,,Immortalised human Schwann cell lines with mutant NF1 (ipNF05.5 and 95.6) and wt NF1 (ipn02.3),0.9,Accept,Experimental Usage
